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Control of Blood Pressure a
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Hypoxia-Induced Hypertension?
Sara AlMarabeh, Mohammed H. Abdulla and Ken D. O’Halloran*
Department of Physiology, School of Medicine, College of Medicine and Health, University College Cork, Cork, Ireland
Renal sensory nerves are important in the regulation of body fluid and electrolyte
homeostasis, and blood pressure. Activation of renal mechanoreceptor afferents triggers
a negative feedback reno-renal reflex that leads to the inhibition of sympathetic
nervous outflow. Conversely, activation of renal chemoreceptor afferents elicits reflex
sympathoexcitation. Dysregulation of reno-renal reflexes by suppression of the inhibitory
reflex and/or activation of the excitatory reflex impairs blood pressure control,
predisposing to hypertension. Obstructive sleep apnoea syndrome (OSAS) is causally
related to hypertension. Renal denervation in patients with OSAS or in experimental
models of chronic intermittent hypoxia (CIH), a cardinal feature of OSAS due to recurrent
apnoeas (pauses in breathing), results in a decrease in circulating norepinephrine
levels and attenuation of hypertension. The mechanism of the beneficial effect of renal
denervation on blood pressure control in models of CIH andOSAS is not fully understood,
since renal denervation interrupts renal afferent signaling to the brain and sympathetic
efferent signals to the kidneys. Herein, we consider the currently proposed mechanisms
involved in the development of hypertension in CIH disease models with a focus on
oxidative and inflammatory mediators in the kidneys and their potential influence on renal
afferent control of blood pressure, with wider consideration of the evidence available from
a variety of hypertension models. We draw focus to the potential contribution of aberrant
renal afferent signaling in the development, maintenance and progression of high blood
pressure, which may have relevance to CIH-induced hypertension.
Keywords: obstructive sleep apnoea syndrome, intermittent hypoxia, reno-renal reflexes, renal afferent nerves,
neurogenic hypertension, sympathoexcitation
INTRODUCTION
Sleep apnoea patients experience periodic interruption of ventilation during sleep epochs
accompanied by arterial hypoxaemia, hypercapnia, and sleep fragmentation. Recurrent apnoeas
can arise from occlusions of the upper airway giving rise to obstructive sleep apnoea syndrome
(OSAS) or periodic suppression of central respiratory drive causing central sleep apnoea
(Prabhakar andKumar, 2010; Javaheri andDempsey, 2013). During apnoea, hypoxaemia stimulates
arterial chemoreceptors in the carotid bodies which transduce afferent signals to hindbrain
regions enhancing sympathetic discharge to peripheral organs (Loredo et al., 2001). Reflex
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sympathoexcitation increases cardiac output, which facilitates
oxygen supply to essential organs. OSAS patients experience
nocturnal hypertension (Kario et al., 2016b). Hypertension
accompanied by elevated sympathetic nervous activity persists
even during normal oxygenation giving rise to diurnal
hypertension (Nagata et al., 2008; Witkowski et al., 2011;
Sharpe et al., 2013). Indeed, OSAS is an independent risk
factor for hypertension and is associated with high incidence of
cardiovascular co-morbidities such as ischaemic heart disease,
heart failure, arrhythmia, and angina (Gottlieb et al., 2010; Shah
et al., 2010; Konecny et al., 2014). Clinical trials addressing
the relationship between OSAS and hypertension estimate that
30–70% of OSAS patients are hypertensive (Ahmad et al., 2017).
The combined evidence points to a strong causal relationship
between OSAS and hypertension.
Exposure to recurrent intermittent hypoxia (IH) of varying
severity and duration is considered the primary stimulus causing
autonomic dysregulation in OSAS patients. Experimental animal
models of IH consistently demonstrate persistent increases in
arterial blood pressure (Fletcher et al., 1992; Lin et al., 2007;
Zoccal et al., 2007b; Sharpe et al., 2013; Yamamoto et al.,
2013; Lucking et al., 2014; Peng et al., 2014; Del Rio et al.,
2016; O’Neill et al., 2019). Indeed, animal models of chronic
IH (CIH) are widely used in the study of pathophysiological
processes associated with sleep apnoea. Exposure to IH increases
sympathetic outflow as evidenced by observations of IH-induced
increases in muscle, renal, and splanchnic sympathetic nerve
activity and increased vascular tone (Narkiewicz et al., 1998;
Soukhova-O’Hare et al., 2006; Peng and Prabhakar, 2008; Silva
and Schreihofer, 2011). Ganglion blockade results in a greater
reduction of blood pressure in CIH-exposed animals compared
with controls, which highlights that sympathoexcitaton is the
primary cause of high blood pressure in this model (Zoccal
et al., 2009a). Table 1 summarizes the details of a variety of CIH
Abbreviations: 5-HT, 5-hydroxytryptamine; AHI, Apnoea-hypopnoea index; Ang
II, Angiotensin II; ARNA, Afferent renal nerve activity; AT-1, Angiotensin 1;
BÖtC, Bötzinger complex; CGRP, Calcitonin gene-related peptide; CIH, Chronic
intermittent hypoxia; COX, Cyclooxygenase; CPAP, Continuous positive airway
pressure; CTGF, Connective tissue growth factor; CVLM, Caudal ventrolateral
medulla; CVO, Circumventricular organs; DOCA, Deoxycorticosterone acetate;
eNOS, Endothelial nitric oxide synthase; ERSNA, Efferent renal sympathetic
nerve activity; ESRD, End-stage renal disease; ET, Endothelin; H2S, Dihydrogen
sulfide; HIF-1, Hypoxia inducible factor 1; HO-1, Heme oxygenase 1;
HO-2, Heme oxygenase 2; ICAM-1, Intercellular adhesion molecule 1;
IH, Intermittent hypoxia; IL-1β, Interleukin-1β; IL-6, Interleukin-6; MCP-1,
Monocyte chemoattractant protein 1; MnPO, Median preoptic nucleus; MT,
Metallothionein; NE, Norepinephrine; NF-κB, Nuclear factor kappa B; NK1,
Neurokinin 1; NMDA, N-methyl-D-aspartate; nNOS, Neuronal nitric oxide
synthase; NO, Nitric oxide; NOX, NADPH oxidase; NTS, Nucleus tractus
solitaries; OSAS, Obstructive sleep apnoea syndrome; PAI-1, Plasminogen
activator inhibitor 1; PGs, Prostaglandins; PVN, Paraventricular nucleus; RAAS,
Renin-angiotensin-aldosterone system; ROS, Reactive oxygen species; RSNA,
Renal sympathetic nerve activity; RTN, Retrotrapezoid nucleus; RTN/pFRG,
Retrotrapezoid nucleus/parafacial respiratory group; RVLM, Rostral ventrolateral
medulla; SFO, Subfornical organ; SHR, Spontaneously hypertensive rats;
sLTF, Sensory long-term facilitation; SNS, Sympathetic nervous system; SOD,
Superoxide dismutase; SP, Substance P; TGF-α, Transforming growth factor α;
TGF-β1, Transforming growth factor β1; TNF-α, Tumor necrosis factor α; TRPV1,
Transient receptor potential vanilloid 1; VCAM-1, Vascular cell adhesion protein
1; VEGF, Vascular endothelial growth factor; VRC, Ventral respiratory column.
protocols utilizing different hypoxic durations and intensities
that evoke cardiorespiratory changes.
Under physiological conditions, acute manipulations of
blood pressure stimulate high- and low-pressure baroreceptors
(Kawada et al., 2011; Oga et al., 2018). Sensory inputs are
integrated in the nucleus tractus solitarius (NTS) in the
dorsal medulla of the brainstem, with resultant inhibition of
sympathetic nervous outflow and activation of parasympathetic
outflow causing blood pressure to be restored to normal (Accorsi-
Mendonça and Machado, 2013). Within minutes to hours,
arterial blood pressure elevation is followed by a significant
increase in urinary output of sodium and water, that is pressure
natriuresis and pressure diuresis, respectively (Hall, 1994).
Moreover, there are accompanying changes in the hormonal
and neural regulation of the kidneys affecting the control of
body fluids, highlighting the role of the kidneys as major
determinants of long-term body fluid homeostasis. Electrolyte
imbalance inevitably occurs if there is a loss of kidney function
with deleterious consequences for blood pressure control. In
OSAS, a variety of mechanisms such as endothelial dysfunction,
inflammation, atherosclerosis, and fibrosis are suggested to
adversely affect renal function resulting in kidney damage
(Adeseun and Rosas, 2010). Of note, OSAS is present in 50-
70% of patients with end-stage renal disease (ESRD) (Ozkok
et al., 2014). Patients with OSAS and concomitant chronic kidney
disease or ESRD are significantly more likely to develop resistant
hypertension (Abdel-Kader et al., 2012). The interplay between
the kidneys and hypertension in OSAS was demonstrated in
a study by Nicholl et al. (2014) showing that treatment of
OSAS patients with continuous positive airway pressure (CPAP),
which resolves recurrent apnoeas, results in a reduction in renin-
angiotensin-aldosterone system (RAAS) activity. Importantly,
the kidneys are richly innervated by afferent and efferent
sympathetic nerves, which play a key role in the maintenance
of normal water and electrolyte balance and renin release in a
mechanism known as the reno-renal reflex (Johns et al., 2011).
Inappropriate afferent signaling through renal afferent nerves is
suggested to interfere with the normal regulation of sympathetic
outflow and exacerbation of efferent nerve activity leading to
hypertension in animal models of renal injury and inflammation
(Abdulla and Johns, 2017). This concept is further supported in
a recent review (Patinha et al., 2017). Subsequently, enhanced
efferent nerve activity arising from RAAS activation leads to
endothelial dysfunction and pathophysiological renal changes
associated with chronic hypertension and chronic kidney disease
(Aroor et al., 2013). Angiotensin II (Ang II) causes renal
vasoconstriction, decreasing renal blood flow, lowering renal
cortical oxygen tension (PO2), which causes renal oxidative stress
(Welch et al., 2005; Emans et al., 2016). Ang II actions are
mediated by enhanced activity of NADPH oxidase (NOX) and
decreased superoxide dismutase (SOD) activity (Welch et al.,
2005). This leads to increased levels of reactive oxygen species
(ROS), which causes the activation of inflammasomes that cause
tubulointerstitial fibrosis, in addition to a decrease in nitric oxide
(NO) bioavailability and uncoupling of endothelial nitric oxide
synthase (eNOS) as seen in CIH models (Badran et al., 2016;
Sogawa et al., 2018). An increase in renal oxidative stress was
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TABLE 1 | Changes in blood pressure and sympathetic nerve activity during exposure to different protocols of chronic intermittent hypoxia (CIH).
Species Duration of
exposure to IH
(days, h/day)
Frequency
of exposure
(cycles/h)
Intensity of
hypoxia
(% of O2)
Blood pressure
increase: CIH vs.
control (%)
Sympathetic nerve activity Catecholamine
levels: CIH vs.
control
References
Human 28, 9 h/day ∼17 13% 4.2%b ↑ MSNA – Gilmartin et al., 2010
Human 14, 8 h/day 30 First
day, 15%.
Remaining 13
days, 13%
6.3%a
7.1%b
7.9% c
↑ MSNA – Tamisier et al., 2011
Rats 35, 6–8 h/day 60 2–3% 12%c Decreased vascular
responsiveness to Ach, but no
change in vascular response to
NE
– Tahawi et al., 2001
Rats 35, 8 h/day 10 10% 16%a
27.2%b
22.5% c
No change in aortic responses to
Ach or phenylephrine
– Ribon-Demars et al.,
2018
Rats 35, 8 h/day 6.6 6% 9.1%a
9.3%b
8.0% c
An increase in vascular
sympathetic activity
↑ 53.2% in NE
levels, no change
in epinephrine
levels.
Zoccal et al., 2007b
Rats 30, 12 h/day 20 8% No change – No change Soukhova-O’Hare
et al., 2006
Rats 30, 6 h/day 48 2–5% 17.5c
18.9 c
– – Lai et al., 2006
Rats 28, 12 h/day 15 10% 17.3%c ↑ RSNA – Marcus et al., 2010
Rats 28, 8 h/day 40 5% 20.5%a ↑ RSNA – Lu et al., 2017b
Rats 21, 8 h/day 15 8–10% No change – – Huang et al., 2010
Rats 21, 8 h/day 40 5% 16%a ↑ RSNA ↑ serum NE Lu et al., 2017a
Rats 21, 8 h/day 30 9% 18.5%a – – Guo et al., 2013
Rats 21, 8 h/day 12 5% 24.4%a
9.0% b
– – Del Rio et al., 2012
Rats 14, 12 h/day 15 10% 6.7%c - Decreased myogenic
contractility of arteries
- Decreased vascular
responsiveness to NE, but not
Ang II
– Phillips et al., 2006
Rats 14, 8 h/day 12 5% 9.2%a No change in vascular
conductance in response to
lumbar sympathetic stimulation
Lucking et al., 2014
Rats 14, 8 h/day 6.6 6% 7.4%c ↑ Splanchnic SNA – Silva and Schreihofer,
2011
Rats 14, 7 h/day 20 5% 14.4%c – – Troncoso Brindeiro
et al., 2007
Rats 10, 8 h/day 6.6 6% 7.0%a
10%b
11.9% c
↑ tSNA during late expiration – Zoccal et al., 2008
Rats 10, 8 h/day 6.6 6% 12.2%a
11.8% c
An increase in vascular
sympathetic activity
– Zoccal et al., 2009a
Rats 7, 8 h/day 10 10% 10.9%c ↑ LSNA – Sharpe et al., 2013
Rats 7, 8 h/day 6 9% 8.7%c – – Yamamoto et al., 2013
Rats 6, 6 h/day 48 2–5% 17.5c
18.9 c
– – Lai et al., 2006
Mice 180, 12 h/day 10 5.7% 20.1%c – – Lin et al., 2007
Mice 35, 8 h/day 20 10% 8.7%a
11.3% c
– Coleman et al., 2010
Mice 28, 8 h/day 12 10% – – ↑ urine NE Keiko et al., 2017
Mice 14, 8 h/day 20 10% No change – – Coleman et al., 2010
RSNA, renal sympathetic nerve activity; LSNA, lumbar sympathetic nerve activity; MSNA, muscle sympathetic nerve activity; SpSNA, splanchnic sympathetic nerve activity. aSystolic
blood pressure, bDiastolic blood pressure, cMean blood pressure; ↑, an increase in corresponding SNA or catecholamines.
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reported in CIH-exposed animals, an outcome which precedes
kidney injury (Lu et al., 2017b; Poonit et al., 2017). Similarly,
a recent study in rats demonstrated that exposure to CIH
provokes kidney injury by an oxidative stress-related mechanism
that involves an imbalance in hypoxia-dependent transcriptional
regulation and downregulation of antioxidant defense (Poonit
et al., 2017). The resultant oxidative stress enhances hypoxia
inducible factor-1 (HIF-1) and the expression of genes including
tumor necrosis factor (TNF-α) and erythropoietin, which are
implicated in kidney fibrosis. Exposure to IH in a mouse model
was associated with renal structural changes such as glomerular
hypertrophy, mesangial matrix expansion, increased expression
of glomerular growth factors and increased cellular apoptosis
(Abuyassin et al., 2018).
In patients with OSAS and attendant hypertension, catheter-
based renal denervation results in a significant decrease in
blood pressure (Witkowski et al., 2011; Kario et al., 2016a).
In 15 patients with moderate-to-severe OSAS, Zhao et al.
(2013) reported a mean reduction of about 12 and 5 mmHg
in daytime systolic and diastolic blood pressure, respectively,
30 days after catheter-based renal denervation. In the same
study, 16 other patients were treated with continuous positive
airway pressure, which lowered systolic and diastolic blood
pressure after 30 days of treatment. Both catheter-based renal
denervation and CPAP resulted in an improvement in apnoea-
hypopnea index (AHI) and increased oxygen saturation. CPAP
treatment was more efficacious than renal denervation in
lowering AHI (approximately 30 events/hr vs. 5 events/hr)
and improving oxygen saturation. However, renal denervation
was more efficacious than CPAP in lowering systolic and
diastolic blood pressure (Zhao et al., 2013). Similarly, a
study by Witkowski et al. (2011) showed a median reduction
of ∼34 and ∼13 mmHg in daytime systolic and diastolic
blood pressure, respectively, 6 months following catheter-based
renal denervation in 10 patients with mild (AHI<15/hour)
and moderate-to-severe OSAS (AHI>15/hour). The study also
reported an improvement in AHI up to 6 months after renal
denervation. However, half of the patients included in this study
had mild OSAS (AHI<,15/hour) and two participants received
concomitant CPAP therapy. Daniels et al. (2017) conducted
a renal denervation study on 20 patients with moderate-to-
severe-OSAS, not receiving CPAP treatment. No significant
improvement in AHI or oxygen saturation was observed
6 months following catheter-based denervation. Noteworthy,
however, was the observation of a significant decrease in
systolic and diastolic blood pressure (office and 24 h-ambulatory
measurements) (Daniels et al., 2017).
Kario et al. (2016a) carried out a large, blinded and
randomized study on patients with resistant hypertension
(systolic blood pressure ≥ 160 mmHg, administered 3 or more
anti-hypertensive medications including a diuretic, at maximum
doses). In this Simplicity HTN-3 trial, 364 patients (26%,
91 patients with OSAS) had catheter-based renal denervation
surgery and 171 patients (32%, 54 patients with OSAS) were
controls. Office and 24 h-ambulatory blood pressure were
measured 6 months after the denervation surgery. OSAS-
resistant hypertensive patients showed a significant reduction
in office, but not ambulatory systolic blood pressure 6 months
after renal denervation. In addition, a significant decrease in
the maximum night-time systolic blood pressure was observed.
However, patients included in this study had self-reported
OSAS. Recently, Warchol-Celinska et al. (2018) conducted a
randomized study on 60 patients diagnosed by polysmnography
with moderate-to-severe OSAS and resistant hypertension. Half
of the participants underwent a catheter-based renal denervation
procedure. Three months following denervation, a significant
decrease in office systolic (−22mmHg) and diastolic (−8mmHg)
blood pressure was reported. Moreover, a significant−12 mmHg
decrease in 24 h-ambulatory systolic blood pressure and −7
mmHg decrease in 24 h-ambulatory diastolic blood pressure
was observed. A decrease in night-time systolic blood pressure
and heart rate was also reported. An improvement in AHI was
shown in patients with and without concomitant CPAP therapy
(Warchol-Celinska et al., 2018). The mechanism by which renal
denervation results in improvement of OSAS severity is not
clearly understood, but it might be related to a decrease in
sodium and water retention; thus, less rostral fluid shift during
sleep in the supine posture. In addition, renal denervation
interrupts the afferent signals traveling centrally from the kidney.
The improvement might be also related indirectly to blood
pressure lowering effects, which attenuate chemoreflexes that
modulate breathing.
A systematic review was reported in 2015 that included 5
studies of the effects of renal denervation on OSAS-hypertensive
patients. The meta-analysis reported 49 patients that showed
a significant improvement in AHI 6 months after catheter-
based renal denervation. Three out of the five studies reported
a significant lowering of office systolic blood pressure (∼-15
mmHg) 6months after renal denervation (Shantha and Pancholy,
2015). It is suggested that failure in nocturnal blood pressure
dipping in sleep apnoea is a risk factor for cardiovascular
outcomes; thus, this index is a more potent predictor of
cardiovascular events than daytime blood pressure (Calhoun,
2010). A recent meta-analysis of 10 randomized clinical trials
conducted between 1946 and 2017 with a total of 7,266
participants has been published (Yu et al., 2017). It showed
no association between cardiovascular events (stroke, acute
coronary syndrome and unstable angina) or number of deaths
with the use of CPAP therapy (Yu et al., 2017). It appears that
CPAP is not a preventive treatment for serious cardiovascular
outcomes that are associated with sleep apnoea. On the other
hand, it was shown that OSAS is positively correlated with
elevated plasma aldosterone levels (Pratt-Ubunama et al., 2007).
Aldosterone induces fluid retention, which can cause intra-
vascular fluid expansion increasing upper airway resistance.
The addition of spironolactone to the normal anti-hypertensive
regimen in 12 moderate-to-severe OSAS patients with resistant
hypertension was associated with a 50% decrease in AHI. It
is suggested that OSAS contributes to aldosterone secretion,
which exacerbates hypertension in the advanced stages of sleep
apnoea (Calhoun, 2010).
During apnoea, hypoxia and hypercapnia stimulate
chemoreflexes, which increase sympathetic drive causing
blood pressure elevation. Renal denervation eliminates the
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increase in renal sympathetic over-activity, which otherwise
causes chronic fluid retention and blood pressure elevation.
However, the mechanisms that result in suppression of
high blood pressure development and progression following
denervation are unclear and many questions remain. This
review discusses the link between CIH-induced renal injury
and hypertension, with a focus on putative changes in reno-
renal reflex mechanisms controlling arterial blood pressure.
We summarize the current understanding of the mechanisms
involved in CIH-induced hypertension as a model of OSAS. In
addition, we draw focus to kidney injury and reno-renal reflexes
that can contribute to neurogenic hypertension, with potential
relevance to CIH-induced hypertension, and hence OSAS.
MECHANISMS OF
CIH-INDUCED HYPERTENSION
CIH protocols that vary in episode frequency, intensity
of hypoxia, and duration are associated with different
cardiorespiratory outcomes. Duration of exposure to CIH has a
major impact on blood pressure, which correlates with elevated
sympathetic activity and increased levels of catecholamines
(Table 1). For a given duration, increased hypoxia intensity
or increased number of hypoxia cycles also correlate with
increased blood pressure. Whereas, exposure to CIH typically
produces a hypertensive phenotype, different protocols may
evoke different mechanisms associated with the development
and maintenance of hypertension. A review of the current
proposed mechanisms based upon experimental evidence is
provided below.
Vascular Dysfunction and Cardiac Output
Increased cardiac output and peripheral arterial resistance
result in blood pressure elevation. Both factors are influenced
by changes in sympathetic nervous activity. In CIH, elevated
sympathetic nerve activity facilitates catecholamine release from
the adrenal medullae, which causes peripheral vasoconstriction
stimulating renin release (Zoccal et al., 2007b; Kumar
et al., 2015). Endothelin (ET) is reported to be increased in
experimental models of CIH and in patients with OSAS. ET
elicits vasoconstriction when it activates ET-A receptors and
vasodilation through its action on endothelial ET-B receptors
(Schneider et al., 2007). In an in vitro study using human
vascular endothelial cells, hypoxia was shown to enhance
ET gene expression leading to increased secretion of ET
(Lanfranchi and Somers, 2001). Immunohistochemistry and
western blotting studies in rats revealed an upregulation of ET-A
receptors in the rat aorta after 3 weeks of exposure to CIH (Guo
et al., 2013). In addition, there was a downregulation of ET-B
receptors, which are known to mediate vasodilation through a
mechanism involving NO. A reduction in NO bioavailability
and downregulation of neuronal nitric oxide synthase (nNOS)
protein expression in CIH-exposed rats was reported by Marcus
et al. (2010). Greater vasoconstriction was attained when an NOS
inhibitor was applied to sham animals, which indicates low basal
NO bioavailability in CIH-exposed animals (Tahawi et al., 2001).
In vivo studies reported an overexpression of ET-A receptors
in the subfornical organs (SFO) of CIH-exposed animals with
an associated increase in blood pressure by 40% compared with
9% in the sham animals when intracerebroventricular ET-1 was
administered (Huang et al., 2010). ET-A receptor-dependent
hypertension was found to be related to oxidative stress, since
pretreatment with a SOD mimetic, tempol, attenuated the
elevation of blood pressure in CIH-exposed rats (Troncoso
Brindeiro et al., 2007). Interestingly, a similar increase in ET-1
and ET receptor expression was observed in patients with
OSAS (Gjørup et al., 2007, 2008). However, treatment with
an antioxidant, carbocysteine, improved AHI and respiratory
parameters in OSAS patients, but did not affect ET-1 levels
(Wu K. et al., 2016).
Exposure to CIH for 35 days resulted in a significant increase
in plasma corticosterone, which can enhance the vasoconstrictor
response to ET-I, Ang II and catecholamines (Zoccal et al.,
2007a). However, ET-1 and norepinephrine (NE) application
on cremaster muscle evoked similar vasoconstrictor responses
after 35 days of exposure to CIH compared with sham rats
(Tahawi et al., 2001). In contrast, responsiveness of gracilis
arterioles to NE was significantly less in CIH-exposed rats,
which may be due to elevated levels of superoxide in CIH-
exposed animals as tempol restored the vasoconstrictor response
to NE (Phillips et al., 2006). An increase in gracilis arteriolar
stiffness was reported, which was also eliminated by tempol
treatment (Phillips et al., 2006). Impaired vasodilatory response
of gracilis arteries and cremaster muscle arteries to acetylcholine
was reported in CIH-exposed rats (Tahawi et al., 2001; Marcus
et al., 2012). Treatment with losartan restored the normal
responsiveness to acetylcholine suggesting a role for Ang II in
impaired vascular reactivity of CIH-exposed rats. In addition,
AT1:AT2 receptor expression was elevated in CIH-exposed rats
compared with sham rats (Marcus et al., 2012). Administration
of N-acetylcysteine relieved blood pressure elevation in CIH-
exposed rats. Increased KCl-mediated constriction of femoral
arteries in CIH-exposed rats was partially reduced following
N-acetylcysteine treatment and completely reversed following
combination treatment of N-acetylcysteine and an arginase
inhibitor. The same combination treatment was associated
with a complete restoration of NOS-dependent relaxation of
femoral and carotid arteries in response to acetylcholine (Krause
et al., 2018). This suggests that N-acetylcysteine works on
mechanisms other than vascular endothelial function. Moreover,
the findings suggest that impaired endothelial expression of
eNOS and arginase 1 is partly responsible for endothelial
dysfunction in CIH-exposed rats. Therefore, development
of CIH-induced hypertension appears partly related to an
oxidative stress mechanism with resultant vascular dysfunction.
On the other hand, 35 days of exposure to CIH did not
alter oxidative and anti-oxidative enzymes activities in the
aorta of rats. Aortic ring responsiveness to acetylcholine and
phenylephrine was not altered after exposure to CIH with
no increase in ET-1 levels in the systemic circulation (Ribon-
Demars et al., 2018), although these divergent findings may
relate to differences between conduit and resistance vessels.
Mechanisms of endothelial dysfunction in CIH models and
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OSAS is reviewed in depth elsewhere (Kanagy, 2009; Lurie, 2011;
Baltzis et al., 2016).
Lucking et al. (2014) demonstrated increased cardiac output
in CIH-exposed rats without significant changes in femoral
vascular conductance (Lucking et al., 2014). This study
demonstrated unaltered vascular conductance in response to
lumbar sympathetic stimulation in CIH-exposed rats. Aortic
compliance was increased and estimated blood volume was
unchanged in CIH-exposed rats. Increased blood pressure
was related to an increase in cardiac output, which was
confirmed by echocardiography (Lucking et al., 2014). It is
suggested therefore that hypertension in the CIH model can
be evoked by over-excitation of the cardiac arm of sympathetic
nervous system (SNS), even before mechanisms of enhanced
peripheral vasoconstriction and endothelial dysfunction are
initiated (Naghshin et al., 2009). This may have less relevance
to human OSAS where increased cardiac output is not
typically observed. Indeed, cardiac fibrosis, inflammation and
apoptosis were reported in CIH-exposed animals, revealing
long-term deleterious outcomes for the CIH-exposed heart
(Wei et al., 2016).
Carotid Body Response to CIH
Disturbances in the autonomic nervous system alter cardiac
output and vascular tone, which can result in blood pressure
elevation. This raises the issue of the cause of autonomic
disturbance in CIH models and OSAS. It is possible that
the carotid bodies and kidneys play a role in driving
sympathoexcitation. Both organs are sensitive to modest
decreases in the partial pressure of oxygen (Patinha et al., 2017)
and are innervated by afferent nerves that project to hindbrain
regions, which play a key role in modulating sympathetic outflow
(Johns et al., 2011; Patinha et al., 2017). Carotid bodies, known
as peripheral chemoreceptors, are clusters of cells located in the
bifurcation of the carotid artery. They are composed of type I
glomus cells and type II glial cells. Type I cells respond to an
impairment in blood flow and mainly to decreasing levels of
arterial PO2 (Andrade et al., 2018). The carotid body chemoreflex
modulates sympathetic drive to the heart and vasculature to
maintain blood pressure. Selective bilateral carotid body ablation
resulted in systolic blood pressure reduction and a decrease in
the respiratory response to hypoxia in CIH-induced hypertensive
rats and spontaneously hypertensive rats (SHR) (Del Rio et al.,
2016; Pijacka et al., 2018). However, carotid body ablation
exaggerated the pressor response to hypercapnia in SHR rats,
which might be due to blunted respiratory response and CO2
accumulation in the blood (Pijacka et al., 2018). In CIH-exposed
animals, there is evidence of carotid body sensitization and
exaggerated responsiveness (Prabhakar et al., 2010; Iturriaga
et al., 2015; Shell et al., 2016). During hypoxia, a decrease in
the partial pressure of oxygen in the blood causes a decrease
in heme oxygenase 2 (HO-2) levels in the carotid bodies
leading to a decrease in carbon monoxide production. Normally,
carbon monoxide suppresses the production of dihydrogen
sulfide (H2S). Therefore, hypoxia increases H2S levels which
stimulates carotid sinus nerve firing (Shell et al., 2016). This
leads to sympathetic over-excitation which causes oxidative stress
in other peripheral organs such as the kidney (Kumar et al.,
2015). Similar to renal sensory receptors, substance P (SP) release
is implicated in carotid body excitation (Peng et al., 2011).
Indeed, ablation of the carotid bodies prevents the development
of CIH-induced hypertension (Prabhakar and Kumar, 2010).
Carotid body ablation restored the normal bradycardia response
to propranolol, which was significantly enhanced after 28 days of
CIH exposure. In addition, heart rate variability was progressively
exaggerated in CIH-exposed rats after the 7th day of exposure
but was restored to normal following surgical ablation of the
carotid bodies (Del Rio et al., 2016). In contrast, carotid body
denervation partially attenuated the increase in sympathetic
activity and heart rate observed after acute upper airway
obstruction (Ferreira et al., 2018). Moreover, administration of
100% oxygen to silence the activity of carotid bodies during
upper airway obstruction reduced, but did not eliminate the
increase in sympathetic nerve activity. These results suggest that
carotid body afferents partially contribute to sympathoexcitation
during apnoea (hypoxic hypercapnia). Inhibition of NTS neurons
reduced phrenic, renal, lumbar, and splanchnic nerve activity and
heart rate during upper airway obstruction (Ferreira et al., 2018).
However, the influence of central chemoreceptor inputs to SNS
activity is likely important during upper airway obstruction as
CO2 and hydrogen ions activate chemosensitive sites, which leads
to sympathoexcitation and resultant cardiorespiratory changes.
Augmented carotid body responsiveness to acute challenges
such as hypoxia or hypercapnia was demonstrated in CIH-
exposed animals (Huang et al., 2009). In addition, stimulation of
the carotid bodies using cyanide resulted in an exaggerated and
prolonged sympathoexcitation represented by greater thoracic
sympathetic nerve activity in CIH-exposed juvenile rats (Braga
et al., 2006). The intensified sympathetic nervous response can
be due to modulations at the level of the central nervous
system (discussed below) or the peripheral nervous system i.e.
potentiated chemoreflexes. A growing body of evidence suggests
enhanced basal afferent signaling from glomus cells of the carotid
bodies under resting conditions after exposure to CIH, known
as sensory long-term facilitation (sLTF) (Figure 2) (Peng et al.,
2009). Previous studies have shown that sLTF is induced by
the enhanced release of 5-hydroxytreptamine (5-HT) in carotid
bodies. 5-HT binds to 5-HT2 receptors, which activates NOX
enzymes causing ROS generation (Peng et al., 2009; Prabhakar
et al., 2010). ROS upregulate ET-A receptors in the carotid bodies
and potentiate carotid body responses to hypoxia (Pawar et al.,
2009). Moreover, it was found that sLTF is induced by a NOX-
superoxide signaling pathway dependent on overexpression of
angiotensin 1 (AT1) receptors and Ang II in the carotid bodies
(Marcus et al., 2010). Losartan, apocynin and AT1a receptor
knockout abolished Ang II-mediated sLTF (Peng et al., 2011).
Subsequently, sensitization of the carotid bodies by Ang II causes
a further increase in renal sympathetic nerve activity (RSNA),
which exaggerates RAAS activity and renal afferent signaling.
Therefore, there is a possibility that persistent activity of the
carotid body is secondary to sympathoexcitation, RAAS system
activation and/or altered renal afferent chemosignals. Although
Ang II and 5-HT induce sLTF of the carotid bodies, there
is evidence that both are involved in the initiation, but not
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the maintenance of sLTF. Roy et al. (2017) discovered that
transient receptor potential vanilloid 1 (TRPV1) channels are
important for the maintenance of sLTF observed in carotid
sinus nerve recordings from isolated perfused carotid body
preparations using an acute intermittent hypoxic hypercapnic
model (Roy et al., 2017). In addition, there is evidence of a
contribution by ATP and P2X receptors in hypoxia-dependent
carotid body activation (Moraes et al., 2018). P2X3 antagonism
reduced hypoxic ventilatory responses in healthy rats, and carotid
sinus nerve responses to hypoxia were attenuated in P2X2-
deficient mice (Moraes et al., 2018). Recently, a potential role
for sites beyond and independent of the carotid body in CIH-
induced hypertension was revealed in studies of IH exposure
in guinea-pigs, which have hypoxia-insensitive carotid bodies
(Docio et al., 2018; Lucking et al., 2018). Exposure of guinea-pigs
to a severe protocol of CIH (30 cycles/hr/day for 30 days) was
associated with blood pressure elevation, an increase in plasma
NE levels and an increase in heart rate (Docio et al., 2018). In
contrast, exposure of guinea-pigs to modest CIH (6 cycles/h/day,
12 days) did not cause hypertension, but was associated with
altered autonomic control of the heart and altered respiratory
timing (Lucking et al., 2018). Together the studies suggest a
primary role for carotid body sensitization in the elaboration
of CIH-induced hypertension, but also convincingly reveal a
capacity for cardiorespiratory impairment and the development
of hypertension in the absence of carotid body plasticity. Among
several potential mechanisms of action, it is plausible that the
kidneys are implicated in CIH-induced autonomic dysfunction
and hypertension as discussed in sections below.
Higher Brain Centers and NTS Plasticity
Inspiratory and expiratory neurons of the brainstem form
inhibitory and excitatory synaptic connections within the
rostral ventrolateral medulla (RVLM), the site of the pre-
sympathetic nerves. These connections generate respiratory-
related signatures on sympathetic nervous outflow shaping the
arterial pressure waveform, known as Traube-Hering waves
(Moraes et al., 2012). The impact of respiration on arterial blood
pressure relates to stimulation of lung stretch receptors and
cyclical changes in the intra-thoracic pressure, which alter stroke
volume and arterial baroreflex control, or modulation of the
central coupling between respiratory complexes and sympathetic
neurons in the ventrolateral medulla (VLM). In healthy rats
at rest, post-inspiratory neurons in the BÖtzinger complex
(BÖtC) inhibit expiratory neurons located in retrotrapezoid
nucleus/parafacial respiratory group (RTN/pFRG). This renders
expiration a passive process with typically no sympathetic
nervous activity expressed in the late expiration phase (E2)
(Machado et al., 2017). In CIH-exposed rats, Zoccal et al. (2008)
reported increased forced expiratory activity in juvenile male
rats after 10 days of exposure to CIH along with a distinctive
discharge of abdominal nerve activity during the E2 phase
of ventilation. In this phase, thoracic sympathetic neuronal
activity was greater than in sham rats (Zoccal et al., 2008).
It was suggested that the expiratory neurons in the BÖtC of
the ventral respiratory column (VRC) suppress the activity of
post-inspiratory neurons on the basis of observed decreases in
cranial vagus nerve activity in the post-inspiratory phase (Zoccal
et al., 2008). This suppression augments the activity of expiratory
neurons and alters excitability of the RVLM neurons. In
addition, post inspiratory neurons normally activate GABAergic
inhibitory neurons of the caudal venterolateral medulla (CVLM).
Therefore, suppression of post inspiratory neurons depresses
the inhibitory CVLM activity, which results in the excitation of
RVLM presympathetic neurons (Zoccal et al., 2009b). Spectral
power analysis of arterial blood pressure of juvenile CIH-exposed
rats showed a significant increase in the high frequency and
low frequency powers as well as greater variable oscillations of
arterial blood pressure, such that CIH-exposed rats exhibit larger
Traube-Hering waves (Zoccal et al., 2009a; Moraes et al., 2012).
This indicates an excessive sympathoexcitation and enhanced
respiratory modulation of sympathetic nervous activity during
expiration in juvenile CIH-exposed animals (Zoccal et al., 2009a).
Barnett et al. (2017) suggested the presence of a direct
connection between second order neurons of the NTS,
which receive peripheral chemoreceptors inputs, and central
chemoreceptors of the RTN. Excitatory inputs from peripheral
chemoreceptors activate late expiratory neurons of the RTN in
the CIH model. This in turn enhances sympathetic discharge
from the brainstem in the late expiratory phase (Barnett et al.,
2017). Molkov et al. (2011) suggested that exposure to CIH
increases the sensitivity of the central chemoreceptors located
in the RTN/pFRG to CO2 levels (Molkov et al., 2011). During
hypercapnia, RTN/pFRG excites the expiratory neurons located
in the caudal VRC, which causes an enhanced discharge of
abdominal nerves during late expiration (Molkov et al., 2011).
This is similar to the enhanced abdominal nerve activity seen
in CIH animals during late expiration under normal levels of
CO2 (Zoccal et al., 2008). This suggests an interaction between
RTN/pFRG chemoreceptors with late expiratory neurons and
presympathetic nerves of the RVLM, which elaborates an
increase in thoracic sympathetic nerve activity (Molkov et al.,
2011). It is also suggested that peripheral chemoreceptors
increase the excitability of pre-inspiratory neurons of the pre-
BÖtC complex. Excessive excitatory inputs from pre-inspiratory
neurons to the late expiratory neurons in the RTN provides
an additional E2 activity even under normal levels of CO2
(Barnett et al., 2017). On the other hand, Souza et al. (2016)
reported an enhanced sympathetic outflow during inspiration
in juvenile female rats exposed to CIH with no changes in
the expiratory activity (Souza et al., 2016). It is proposed that
enhanced sympathetic discharge mediated by altered respiratory
modulation presenting cyclically causes more pronounced
vasoconstriction and blood pressure elevation compared with
sustained nervous activity, a mechanism that may contribute to
CIH-induced hypertension (Souza et al., 2016).
Immunohistochemical studies revealed a 20% increase in the
expression of P2X3 and P2X4 receptors in the RVLM region
after 10 days of exposure to CIH. ATP injection in these animals
resulted in larger increases in thoracic sympathetic nerve activity
compared with sham animals (Zoccal et al., 2011). Additionally,
a previous study reported an increase in the expression of
N-methyl-D-aspartate (NMDA) and AMPA receptors in the
caudal region of the NTS (cNTS), which is the main site for
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integration of chemoreceptors inputs. This explains the enhanced
sympathetic activity after glutamate injection in the cNTS in
CIH-exposed rats compared with healthy rats (Costa-Silva et al.,
2012). Other studies showed that exposure to CIH is associated
with the upregulation of glutamatergic neurons in the NTS and
increased expression of c-fos and fosB in the RVLM (Oyarce and
Iturriaga, 2018). Therefore, increased peripheral afferent activity
causes exaggerated central neural activity, which increases the
production of ROS and cytokines in the NTS. This induces
microglial activation, which stimulates further increases in the
levels of inflammatory cytokines. Exposure to CIH for 21 days
caused an elevation of pro-inflammatory cytokines in the NTS
and RVLM (Oyarce and Iturriaga, 2018). This hyperactivates
NTS and PVN neurons, which increases renal sympathetic nerve
activity and Ang II secretion. Conversely, continuous afferent
neural activity causes a depression of NTS neurotransmission.
Indeed, in CIH-exposed animals there is depression of glutamate-
dependent neurotransmission and a decrease in the number
of NTS active synapses (Almado et al., 2012). This alters
the integration of sensory inputs including baroreceptors
and chemoreceptors, which might contribute to sustained
sympathoexcitation even during normoxia (Kline, 2010).
Neural activity of the hypothalamic paraventricular nucleus
(PVN) is controlled by excitatory neurotransmitters such as
glutamate and inhibitory neurotransmitters including NO. In
normal healthy rats, the PVN represents the central regulator
that controls renal sympathetic discharge and blood pressure
regulation (McBryde et al., 2018). Endogenous nNOS knockout
selectively in the PVN of healthy Wistar rats resulted in 70%
increase in RSNA with a significant gradual increase in blood
pressure reaching a plateau after 10 days (McBryde et al.,
2018). Exposure to IH for 14 days resulted in a decrease in
plasmalemmal density of NMDA NR1 in n-NOS containing
dendrites with a reduction in NMDA-evoked currents in the
PVN prior to the onset of blood pressure elevation (Coleman
et al., 2010). Nevertheless, NO production was not altered after
14 days of exposure to IH (Coleman et al., 2010). Of interest,
blood pressure elevation after exposure to a different protocol of
CIH was not associated with changes in nNOS expression or NO
production in the NTS region (Pajolla et al., 2009). In contrast,
prolonged exposure to CIH (35 days) caused an accumulation
of NMDA NR1 in the cytoplasm of n-NOS containing dendrites
in addition to suppression of NO production after the onset
of hypertension (Coleman et al., 2010). Importantly, GABA-
containing and nNOS-containing interneurons of the PVN
region receive afferent inputs from the NTS that mediate
arterial baroreflex control of blood pressure (Affleck et al.,
2012; Abdulla and Johns, 2013, 2014). Therefore, this supports
the possibility that the normal regulatory baroreflex might be
dysregulated or retuned after exposure to CIH, an important
issue under investigation with variable answers in literature
(discussed further below in “Renal oxidative stress, inflammation
and CIH-induced hypertension”).
Kidney Response to CIH
Exposure to CIH and resultant decreases in renal oxygenation
stabilize the HIF-1α subunit (Haase, 2006). HIF-1 is a
transcription factor composed of a hypoxia-sensitive alpha
subunit and a constitutive beta subunit. HIF-1 drives the
expression of genes that encode erythropoietin, heme oxygenase
1 (HO-1) and vascular endothelial growth factor (VEGF),
responsible for fibrosis and angiogenesis (Haase, 2006; Sun
et al., 2012; Lu et al., 2017b; Abuyassin et al., 2018) (Table 2).
Erythropoietin increases red blood cell production and oxygen
carrying capacity as indicated by increased haematocrit in
CIH-exposed animals (Saxena et al., 2015). O’Neill et al.
(2019) recently described persistent reductions in renal cortical
oxygenation following exposure to long-term, but not short-
term IH. The kidneys are also affected by sensitization of the
carotid bodies to hypoxia. The exaggerated response of the
carotid bodies results in an increase in RSNA, which stimulates
the release of catecholamines from the adrenal medullae and
activates the RAAS. As part of this response, there is increased
vasoconstriction and enhanced renal tubular sodium and water
reabsorption leading to increased renal metabolic demand.
Table 2 summarizes a number of studies in CIH models
whereby decreased blood oxygenation was associated with
oxidative stress and inflammation in renal tissues. Inflammatory
metabolites trigger excitatory sensory responses mediated by
renal chemoreceptors, which signal to the NTS and RVLM
brain regions. This results in excessive activation of sympathetic
nervous outflow, which causes further RAAS activation in a
vicious cycle, as in the case of renal ischemic reperfusion injury
(Cao et al., 2017). RAAS activation induces Ang II release, which
stimulates the circumventricular organs (CVO) of forebrain
nuclei such as the SFO and median preoptic nucleus (MnPO)
(Sharpe et al., 2013; Saxena et al., 2015). Activation of CVO
regions in turn stimulates PVN and contributes to sustained
sympathetic outflow (Sharpe et al., 2013). Knockout of AT1a
receptors of the SFO attenuated blood pressure and FosB staining
in PVN andMnPO of CIH-exposed animals (Saxena et al., 2015).
In recent years, there has been increased interest in the
potential role played by renal nerves in mediating a response
from the injured kidney leading to hypertension in the CIH
model. Witkowski et al. (2011) observed a decrease in blood
pressure after catheter-based renal denervation in OSAS patients.
A significant decrease in systolic and diastolic blood pressure
has been observed up to 6 months following surgery in human
studies (Witkowski et al., 2011; Kario et al., 2016a). Similar
findings were reported after renal denervation in a mouse
model of exposure to IH for 4 weeks (Kario et al., 2016a;
Keiko et al., 2017), where a decrease in blood pressure and
an associated reduction in circulating NE and angiotensinogen
levels were reported. It has also been shown that catheter-
based renal denervation is effective in decreasing hypoxia-
induced nocturnal blood pressure elevation (Kario et al., 2016b).
Kidney perfusion with hypoxic blood increases femoral perfusion
pressure in rabbits, which was abolished by renal denervation
(Ashton et al., 1994). Renal denervation and anti-oxidant
treatment significantly decreased renal oxidative stress and blood
pressure in CIH models (Xiang et al., 2010; Keiko et al., 2017;
Lu et al., 2017b).
Renal denervation or adrenal demedullation eliminates
chronic hypertension in CIH-exposed rats (Bao et al., 1997),
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TABLE 2 | Oxidative stress and inflammatory biomarkers (↑, an increase; ↓, a decrease) in animals exposed to different protocols of CIH.
Biomarker Level Sample Duration of
exposure to IH
(days, h/day)
Species Frequency
of exposure
(cycles/h)
Intensity of
hypoxia
(% of O2)
References
8-hydroxyl
deoxy-guanosine
↑ Urine 28 days, 8 h/day Mice 12 10% Keiko et al., 2017; Snyder et al.,
2017
Apoptotic cells ↑ Kidney
tissue
56 days, 12 h/day Mice 30 8% Sun et al., 2012; Ding et al.,
2016; Wu X. et al., 2016; Lu
et al., 2017a,b; Zhang X. B.
et al., 2018; Zhang Y. et al., 2018
↑ Kidney
tissue
21 days, 8 h/day Rats 40 5%
28 days, 8 h/day
↑ Kidney
tissue
112 days, 8 h/day Rats 30 5–6%
↑ Kidney
tissue
35 days, 8 h/day Rats 60 6–7%
↑ Kidney
tissue
42 days, 8 h/day Mice 30 6–8%
84 days, 8 h/day 5–7%
Bax/Bcl-2 ↑ Kidney
tissue
35 days, 8 h/day Rats 60 6–7% Wu X. et al., 2016; Abuyassin
et al., 2018; Zhang Y. et al., 2018
↑ Kidney
tissue
60 days, 12 h/day Mice 60 8%
↑ Kidney
tissue
42 days, 8 h/day Mice 30 6–8%
Caspase 3 ↑ Kidney
tissue
42 days, 8 h/day Mice 30 6–8% Zhang X. B. et al., 2018; Zhang
Y. et al., 201884 days, 8 h/day 5–7%
Catalase ↓ Kidney
tissue
28 days, 8 h/day Rats 40 5% Lu et al., 2017b
Collagen 1 ↑ Kidney
tissue
56 days, 12 h/day Mice 30 8% Wu et al., 2015; Zhang Y. et al.,
201842 days, 8 h/day Mice 30 6–8%
Collagen IV ↑ Kidney
tissue
42 days, 8 h/day Mice 30 6–8% Zhang Y. et al., 2018
Connective tissue
growth factor (CTGF)
↑ Kidney
tissue
56 days, 12 h/day Mice 30 8% Sun et al., 2012; Wu et al., 2015;
Lu et al., 2017b; Abuyassin
et al., 2018↑ Kidney
tissue
28 days, 8 h/day Rats 40 5%
↑ Kidney
tissue
21 days, 12 h/day MT
knockout
mice
30 8%
↑ Kidney
tissue
60 days, 12 h/day Mice 60 8%
ERK1/2
phosphorylation
↑ Kidney
tissue
3 days, 14 days
and 56 days, 12
h/day
Mice 30 8% Sun et al., 2012; Wu X. et al.,
2016
↑ Kidney
tissue
35 days, 8 h/day Rats 60 6–7%
HIF-1α ↑ Kidney
tissue
56 days, 12 h/day Mice 30 8% Sun et al., 2012; Lu et al.,
2017b; Poonit et al., 2017;
Abuyassin et al., 2018↑ Kidney
tissue
28 days, 8 h/day Rats 40 5%
↑ Kidney
tissue
14 and 28 days,
7.5 h/day
Rats 40 9%
↑ Kidney
tissue
56 days, 12 h/day Mice 60 8%
ICAM-1 ↑ Kidney
tissue
3 days, 7 days and
56 days, 12 h/day
Mice 30 8% Sun et al., 2012; Wu et al., 2015
IFN-γ, IL-10, IL-13,
IL-2, IL-4, IL-5
↓ RVLM 7 days, 8 h/day Mice 10 10% Snyder et al., 2017
IL-1β ↓ RVLM 7 days, 8 h/day Mice 10 10% Snyder et al., 2017
↑ Kidney
tissue
NA, 10 h/day Mice 60 7% Wu et al., 2018
(Continued)
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TABLE 2 | Continued
Biomarker Level Sample Duration of
exposure to IH
(days, h/day)
Species Frequency
of exposure
(cycles/h)
Intensity of
hypoxia
(% of O2)
References
IL-6 ↑ Kidney
tissue,
Plasma
28 days, 8 h/day Rats 40 5% Wu X. et al., 2016; Lu et al.,
2017b; Snyder et al., 2017;
Zhang Y. et al., 2018
↑ Serum 35 days, 8 h/day Rats 60 6–7%
↓ RVLM 7 days, 8 h/day Mice 10 10%
↑ Kidney
tissue
42 days, 8 h/day Mice 30 6–8%
JNK phosphorylation
and P38
phosphorylation
↑ Kidney
tissue
35 days, 8 h/day Rats 60 6–7% Wu X. et al., 2016
Kidney morphology No change
(Hematoxylin and
Eosin)
Kidney
tissue
3 days, 7 days, 21
days and 56 days,
8 h/day
Mice 30 8% Wu et al., 2015, 2018; Lu et al.,
2017b; Poonit et al., 2017;
Zhang X. B. et al., 2018; Zhang
Y. et al., 201884 days, 8 h/day 5–7%
No change
(Hematoxylin and
eosin)
Kidney
tissue
28 days, 8 h/day Rats 40 5%
Glomeruli
dilatation and
hypertrophy of
epithelial cells of
tubules
Kidney
tissue
14 and 28 days,
7.5 h/day
Rats 40 9%
Tubular
vacuolization,
tubular epithelial
cell exfoliation,
inflammatory cell
infiltration, and
thickening of
glomerular
basement
membrane
Kidney
tissue
NA, 12 h/day Mice 60 7%
Tubular atrophy Kidney
tissue
42 days, 8 h/day Mice 30 6–8% Zhang Y. et al., 2018
Liver-type fatty
acid-binding protein
(L-FABP)
↑ Urine 28 days, 8 h/day Mice 12 10% Keiko et al., 2017
Malondialdehyde ↓ Kidney
tissue
3 days and 14
days, 12 h/day
Mice 30 8% Xiang et al., 2010; Sun et al.,
2012; Wu et al., 2015, 2018
↑ Kidney
tissue
56 days, 12 h/day Mice 30 8%
↑ Kidney
tissue
7 days, 12 h/day Mice and
methionine
(MT)
knockout
mice
30 8%
↑ Serum 42 days, 7 h/day Rats 20 6–8%
↑ Kidney
tissue
NA, 10 h/day Mice 60 7%
MCP-1 ↑ Kidney
tissue
42 days, 8 h/day Mice 30 6–8% Zhang Y. et al., 2018
Metallothionen ↑ Kidney
tissue
3 days and 7
days, 12 h/day
Mice 30 8% Wu et al., 2015
↓ Kidney
tissue
14 and 56 days,
12 h/day
Mice 30 8% Sun et al., 2012; Wu et al., 2015
(Continued)
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TABLE 2 | Continued
Biomarker Level Sample Duration of
exposure to IH
(days, h/day)
Species Frequency
of exposure
(cycles/h)
Intensity of
hypoxia
(% of O2)
References
Mn SOD and Cu/Zn
SOD
↓ Kidney
tissue
14 days and 28
days, 7.5 h/day
Rats 40 9% Poonit et al., 2017
NADPH
dehydrogenase
↑ Kidney
tissue
3 days and 7
days, 12 h/day
Mice 30 8% Wu et al., 2015
↓ 56 days, 12 h/day Mice
NF-κB ↑ Serum 35 days, 8 h/day Rats 60 6–7% Wu X. et al., 2016
Nitrotyrosine and
caspases
↑ Kidney
tissue
28 days, 8 h/day Rats 40 5% Lu et al., 2017b
Nrf2 and HO-1 ↑ Kidney
tissue
3 days, 12 h/day Mice 30 8% Sun et al., 2012; Wu et al., 2015
Normal Kidney
tissue
56 days, 12 h/day Mice
↑ Kidney
tissue
3 days, 7 days and
21 days, 12 h/day
Mice
MT
knockout
mice
↓ Kidney
tissue
56 days, 12 h/day Mice
MT
knockout
mice
Oxidative low- density
lipoproteins
↑ Serum 42 days, 7 h/day Rats 20 6–8% Xiang et al., 2010
Oxidized cysteine
(CysSSP)
↑ Kidney
tissue
14 days, 10.5
h/day
Rats 5.6 5% Coelho et al., 2018
Plasminogen activator
inhibitor-1 (PAI-1)
↑ Kidney
tissue
3 days, 7 days and
56 days, 12 h/day
Mice 30 8% Sun et al., 2012; Wu et al., 2015
↑ Kidney
tissue
7 days, 12 h/day MT
knockout
mice
Reduced cysteine
(CysSH)/CysSSP
↓ Kidney
tissue
(medulla)
14 days, 10.5
h/day
Rats 5.6 5% Coelho et al., 2018
Kidney
tissue (cortex)
21 days, 10.5
h/day
Renal fibrosis (Sirius
red stain)
↑ Kidney
tissue
14 days, 8 h/day Rats 40 5% Lu et al., 2017b
↑ Kidney
tissue
56 days, 12 h/day Mice 30 8% Sun et al., 2012; Wu et al., 2015
ROS ↑ Kidney
tissue
112 days, 8 h/day Rats 30 5–6% Ding et al., 2016
SOD ↑ Kidney
tissue
21 days, 8 h/day Rats 40 5% Lu et al., 2017a,b; Poonit et al.,
2017; Wu et al., 2018
↓ Kidney
tissue
28 days, 8 h/day Rats 40 5%
↓ Serum 14 and 28 days,
7.5 h/day
Rats 40 9%
↓ Kidney
tissue
NA, 10 h/day Mice 60 7%
TGF-α ↑ Kidney
tissue
28 days, 8 h/day Rats 40 5% Lu et al., 2017b
TGF-β ↑ Kidney
tissue
28 days, 8 h/day Rats 40 5% Wu et al., 2015; Lu et al., 2017b;
Abuyassin et al., 2018
↑ Kidney
tissue
56 days, 12 h/day Mice 30 8%
(Continued)
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TABLE 2 | Continued
Biomarker Level Sample Duration of
exposure to IH
(days, h/day)
Species Frequency
of exposure
(cycles/h)
Intensity of
hypoxia
(% of O2)
References
↑ Kidney
tissue
21 days, 12 h/day MT
knockout
mice
30 8%
↑ Kidney
tissue
60 days, 12 h/day Mice 60 8%
TNF-α ↑ Kidney
tissue,
plasma
28 days, 8 h/day Rats 40 5% Wu X. et al., 2016; Lu et al.,
2017b; Snyder et al., 2017;
Zhang Y. et al., 2018
↑ Serum 35 days, 8 h/day Rats 60 6–7%
↓ RVLM 7 days, 8 h/day Mice 10 10%
↑ Kidney
tissue
42 days, 8 h/day Mice 30 6–8%
Vascular cell adhesion
protein 1 (VCAM-1)
↑ Kidney
tissue
7 and 56 days, 12
h/day
Mice 30 8% Sun et al., 2012; Wu et al., 2015
↑ Kidney
tissue
7 days, 12 h/day MT
knockout
mice
VEGF ↑ Kidney
tissue
60 days, 12 h/day Mice 60 8% Abuyassin et al., 2018
related to a decrease in epinephrine secretion shown in the same
study. Epinephrine stimulates NE release from postganglionic
neurons, which induces vascular constriction and serves as a
stimulus for RAAS activation (Bao et al., 1997). In support of
this, plasma renin activity was elevated four-fold following IH
exposure and was restored to baseline levels by renal denervation.
In addition, losartan administration eliminated blood pressure
elevation after IH exposure (Fletcher et al., 1999), suggesting
that hypoxia, through carotid body activation, enhances RSNA,
and Ang II release. Moreover, hypoxia induces the release
of ischaemic metabolites and kidney injury, which indirectly
enhance RSNA and RAAS. Finally, denervation of the adrenal
medullae reduces NE release and eliminates the stimulus that
activates renal sympathetic nerves, which are part of the reno-
renal reflex (Bao et al., 1997). Overall, this reveals the presence
of signals originating from hypoxic/injured kidneys that cause
over-excitation of RSNA and blood pressure elevation, which are
at least partly attributed to renal oxidative stress. These studies
point to an important role played by renal nerves in mediating
hypertension in the CIHmodel. The exact mechanisms, however,
are not established.
RENAL SENSORY AFFERENT NERVES
Renal sensory receptors are present as free nerve endings in
the kidney that project to thoracolumbar region of dorsal root
ganglion primarily from T12 to L3 (Weiss and Chowdhury,
1998). Afferent fibers synapse with interneurons within the
ipsilateral dorsal horn in laminae I and laminae III to V. They
project to brain sites including NTS, RVLM, SFO and PVN
(Johns et al., 2011). There is considerable interest in the role
of renal afferents in the control of sympathetic outflow and
regulation of the cardiovascular system.
The location of the renal sensory nerve fibers has been
identified using highly specific wheat germ agglutinin
horseradish peroxidase nerve tracing (Marfurt and Echtenkamp,
1991). Immunohistochemistry has also been implemented
to explore renal sensory nerves by tracking calcitonin gene-
related peptide (CGRP) and SP as specific neurotransmitters
of sensory neurons (Gontijo and Kopp, 1994; Kopp et al.,
2007; Kopp, 2011b; Mulder et al., 2013). In the kidney, the
sensory fibers travel parallel to the renal vein, renal artery and
ureter entering the kidney at the hilus. The nerve endings of
these sensory fibers are predominantly found in the ureter and
the muscular layer of the renal pelvic wall with some located
in the uroepithelial layer of the renal pelvis (Marfurt and
Echtenkamp, 1991). This is evidenced by the presence of SP in
the space between the muscular layer and the epithelial cells
of renal pelvic wall (Feng et al., 2008) indicating the presence
of sensory nerves in the renal pelvis. Similarly, CGRP was
identified in the renal pelvic wall in previous studies in rat and
sheep (Booth et al., 2015b; Foss et al., 2015) and was utilized
to examine the validity of renal denervation in these studies.
Marfurt and Echtenkamp (1991) identified renal afferent nerves
in the renal cortex by labeling these fibers with wheat germ
agglutinin-horseradish peroxidase. However, labeling was not
detected in the renal medulla or papilla. Immunolabeling by
the same group indicated the presence of afferent fibers in
the interlobular and arcuate arteries. Some of these afferent
sensory fibers were stimulated when the renal artery and renal
vein were obstructed (Booth et al., 2015a; Xu et al., 2015).
Similarly, an elevation in renal venous pressure resulted in
an increase in urinary sodium excretion and urine flow rate.
This response was not attenuated when lidocaine, a local
anesthetic, was injected into the renal pelvis (Kopp et al.,
1985) providing evidence for the presence of sensory nerves
in the renal vein separate from those present in the renal
pelvis. In general, sensory nerve endings in the kidney are of
two types: mechanoreceptors and chemoreceptors (Stella and
Zanchetti, 1991). In rats, around 76% of afferent nerves are
unmyelinated slow conducting axons while some 19% are thin
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myelinated and only 5% are rapidly conducting myelinated fibers
(Knuepfer and Schramm, 1987).
Mechanoreceptors are sensitive to stretch induced by volume
expansion (VE), capsaicin or any stimulus that increases SP and
CGRP formation. However, a group of renal sensory nerves were
found to be responsive to ischemia due to renal artery occlusion
or due to cyanide but not to pelvic pressure elevation (Recordati
et al., 1978). This suggests that these sensory nerves are sensitive
to the presence of ischemic mediators rather than mechanical
stretch and were therefore referred to as chemoreceptors.
Ischemia sensitive receptors are termed R1 chemoreceptors that
are silent in their resting conditions but trigger a slow response
characterized by long duration action potentials and their signals
are transported mainly through non-myelinated nerve fibers
(Recordati et al., 1978). In contrast, R2 chemoreceptors are active
in the resting state and are slowly-adapting insofar as their firing
continues 15–20min after death. They are activated by renal
ischemia and by backflow of hypertonic or hyperosmotic urine
(Recordati et al., 1980; Goodwill et al., 2017). Studies pointed
toward a role for chemoreceptors in initiating an excitatory
reno-renal reflex, which contributes to sympathoexcitation and
blood pressure elevation (Calaresu et al., 1976; Recordati
et al., 1978; Goodwill et al., 2017). To distinguish the role of
mechanoreceptors from that of chemoreceptors, an increase in
renal pelvic pressure over a physiological range (2.5–10 mmHg)
was utilized to activate the mechanoreceptors while a solution of
450mM NaCl was used to stimulate the chemoreceptors (Kopp
et al., 1998b; Wainford and Frame, 2017). However, there is still
a scarcity in the literature of studies that differentiate between
mechanoreceptors and chemoreceptors in terms of structure
and function. Indeed, more studies are required to identify the
different roles of these receptors in the reflex regulation of kidney
and cardiovascular functions.
ACTIVATION OF RENAL SENSORY
NEURONS AND RENO-RENAL REFLEXES
Signaling pathways involved in sensory mechanoreceptor
activation have been extensively studied by Kopp
(2015) employing pharmacological agents and direct recording
of renal afferent nerve signals in rats. The renal afferent and
efferent nerve fibers were found to exist in close proximity
to each other according to histological studies (Kopp et al.,
2007; Kopp, 2011b). This points to an interaction between
afferent and efferent sympathetic nerves that play a key role
in the control of body water and sodium balance, modulated
by dietary sodium intake. This interaction is also modified by
NE, ET-1 and Ang II (Kopp et al., 2002a, 2003, 2011; Kopp,
2011b). The renal pelvic wall contains AT-1 and ET receptors;
ET-A receptors are located in the smooth muscle cell layer of
the pelvic wall, with some immunoreactivity in blood vessels,
while ET-B immunoreactive fibers are found in the uroepethelial
layer of the pelvis running close to CGRP-labeled nerve fibers
(Kopp et al., 2003, 2009).
Activation pathways of mechanoreceptors are via two main
routes: neurokinin 1 receptor (NK1) activation by SP and/or
stimulation of TRPV1 as illustrated in Figure 1. Some signaling
pathways require the presence of cyclooxygenase (COX) enzyme
and prostaglandins (PGs) as previously reported (Kopp and
Smith, 1993). This explains why there is suppression of afferent
renal nerve activity (ARNA) in rats treated with a COX-2
inhibitor or when their diet is deficient of essential fatty acids
required for PG synthesis (Kopp and Smith, 1993; Kopp et al.,
2000). The pathway that involves PGE2 binding to its receptors
results in the activation of the cAMP/PKA signaling cascade
that ultimately results in SP and CGRP production (Kopp et al.,
2002b). This was further confirmed by immunohistochemical
studies showing the co-localization of CGRP and PG receptors
in sensory nerve terminals of the renal pelvic wall (Kopp et al.,
2004). It should also be noted that the effect of SP on renal
sensory afferents is associated with increased natriuresis and
diuresis. This natriuretic and diuretic response relates to two
mechanisms. First, SP activates an inhibitory reno-renal reflex to
decrease sympathetic outflow, thus, increasing water and sodium
excretion. Second, SP induces pelvic contractions that facilitate
urine movement into the bladder (Kopp et al., 1998a). The role of
CGRP in renal sensory nerve endings is not extensively studied
but there is convincing evidence that CGRP stimulates renal
afferent nerves and increases renal sodium excretion (Gontijo
and Kopp, 1994, 1999; Xie et al., 2008).
Efferent nerves traveling into the kidneys are sympathetic in
nature and are mainly located in the corticomedullary region
and to a lesser extent, in the renal pelvic wall. The renal efferent
nerves are intertwined with afferent nerves in the same nerve
fiber bundle (Kopp et al., 2007; Kopp, 2011a). Afferent nerves
are major players in the autonomic system response leading
to increased activity of sympathetic efferents and hypertension
(Sharpe et al., 2013). Efferent sympathetic stimulation increases
NE release, which binds to α1 and α2 adrenoreceptors in the
renal pelvic wall (Kopp et al., 2007). NE stimulates renin release
followed by RAAS activation, which results in increased renal
sodium and water reabsorption (Guyton, 2010). This causes
an increase in ureter and renal pelvic pressure that activates
mechanosensitive receptors through the opening of TRPV1 and
release of SP, which in turn enhances ARNA. Renal afferent
nerve stimulation provides a negative feedback mechanism that
causes reflex natriuresis and diuresis i.e., a fall in efferent
renal sympathetic nerve activity (ERSNA) (Kopp, 2015). This is
known as the inhibitory reno-renal reflex, which protects against
sympathetic over-activity and blood pressure elevation.
DIETARY SODIUM, RENAL SENSORY
RECEPTORS, AND RENO-RENAL REFLEX
The effect of dietary sodium on the interaction between renal
afferent and efferent nerves in the control of sodium homeostasis
has been studied under different sodium loading states. Indeed,
challenges to sodium balance presents a reno-renal reflex
response characterized by afferent renal nerve activation and
sympathoexcitation. For example, low sodium diet consumption
was found to be associated with higher levels of NE and
Ang II (Anderson et al., 1989; Shao et al., 2013). NE binds
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FIGURE 1 | A representation of possible pathways that enhance renal afferent nerve activity in a renal afferent nerve ending. B2, Bradykinin receptor type 2; PKC,
protein kinase C; NE, norepinephrine; ET1, endothelin 1; ETA and ETB, endothelin receptor type A and type B; PKA, phosphokinase A; SP, substance P; CGRP,
calcitonin gene related peptide; NK1, neurokinin receptor 1; TRPV1, Transient receptor potential cation channel; NMDA, N-methyl-D-aspartate receptors; ARNA,
afferent renal nerve activity. Solid lines represent excitatory pathways and dashed lines represent inhibitory pathways. Chronic intermittent hypoxia may evoke aberrant
renal afferent signaling contributing to hypertension through action on one or more of the above signaling mechanisms.
to α2 adrenoreceptors while Ang II binds to AT1 receptors
on renal afferents nerve endings, and both inhibit the PGE2
pathway leading to suppressed ARNA (Kopp et al., 2003, 2011).
This effect of Ang II is partly-mediated through ET-1 binding
to ET-A receptors (Kopp et al., 2009). In support of this
notion, it was found that ET-A receptors are overexpressed
when RAAS is activated in rats fed a low sodium diet or
in congestive heart failure (Kopp et al., 2010). Kopp et al.
(2002a) also showed that low sodium diet increases the threshold
for mechanoreceptor activation from 2.5 to 5 to 7.5 mmHg.
This decrease in mechanoreceptor sensitivity to increased pelvic
pressure causes suppression of the inhibitory reno-renal reflex,
hence sympathoexcitation ensues resulting in the retention of
more sodium.
Alternatively, when dietary sodium intake is high, an
inhibitory reno-renal reflex decreases ERSNA with resultant
enhanced sodium excretion. This is associated with activation
of ET-B receptors, which stimulates PGE2-mediated effects on
ARNA (Kopp et al., 2009). These findings suggest that ERSNA is
inappropriately elevated if there is a suppression of the inhibitory
reno-renal reflex.
OTHER RENAL SENSORY RECEPTORS
AND THEIR ROLE IN
RENO-RENAL REFLEXES
TRPV1 is a ligand gated non-selective channel, which can be
activated by heat, cations and vanilloid compound derivatives.
TRPV1 is found in sensory neurons in the upper part of the
ureter and neurons between uroepithelial and the smooth muscle
cell layer of the renal pelvis (Zhu et al., 2007; Feng et al., 2008).
TRPV1 allows the influx of Na+, Mg2+ and Ca2+ leading to
SP and CGRP release in sensory neurons (Figure 1). This was
supported by immunoblotting studies showing that SP, CGRP
and TRPV1 are co-localized in the same sensory nerve, which
was suggested to havemechanosensitive characteristics (Xie et al.,
2008). TRPV1 is also present in renal afferent chemosensitive
receptors as ipsilateral infusion of capsaizipine, a selective TRPV1
antagonist was shown to block contralateral diuresis triggered
by hypertonic saline injection (Zhu et al., 2007). When TRPV1
is stimulated either by its selective agonist capsaicin or by the
compound resiniferatoxin, it was found that this initiates an
inhibitory reno-renal reflex. This effect was attenuated when a
NK1 receptor antagonist was injected into the renal pelvis (Xie
et al., 2008) suggesting cross-talk between TRPV1 and NK1
receptors in renal afferent neurons. Different signaling cascades
were found to be activated through NK1 receptors including
phospholipase A, which in rat kidney epithelial cells was shown
to increase arachidonic acid levels and activate cyclic-AMP/PKA
signaling mechanisms (Steinhoff et al., 2014). Although NK1
receptors play a key role in renal afferent nerve activation, their
exact intracellular signaling pathway in the renal pelvis wall is not
fully understood.
In addition to TRPV1 effects, bradykinin is a pro-
inflammatory mediator that has been extensively studied
and shown to activate afferent renal nerves (Smits and Brody,
1984; Maggi et al., 1992; Barry and Johns, 2015; Hindermann
et al., 2017). It was suggested that bradykinin excites the afferent
renal nerves via activation of renal chemoreceptors (Ashton et al.,
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1994). Indeed, Kopp et al. (2000) demonstrated the presence
of bradykinin B2 receptors on sensory nerve fibers. In general,
bradykinin binds to its receptors and activates protein kinase
C, phospholipase A2 and the release of arachidonic acid (Kopp
et al., 2000; Johns et al., 2011). Notably, local inflammation
of peripheral sensory neurons stimulates B2 receptors to
phosphorylate TRPV1 channels by Gq/11 dependent mechanism
indicating cross-talk between these receptors (Steinhoff et al.,
2014). Similarly, a previous report indicated that B1 receptors are
upregulated in inflammatory diseases (Petho and Reeh, 2012).
Bradykinin causes different renal hemodynamic changes
depending on the route of administration. Intra-renal bradykinin
elevates RSNA, decreases natriuresis and diuresis in the
contralateral kidney with an immediate increase in heart rate,
blood pressure and vascular resistance. This effect is abolished by
renal denervation or by ganglionic blockade (Smits and Brody,
1984; Barry and Johns, 2015; Abdulla et al., 2016). However,
intravenous injection of the same dose of bradykinin did not
induce any significant changes in blood pressure or heart rate
(Foss et al., 2015), rather it produced mesenteric vasodilation
(Smits and Brody, 1984). The decrease in vascular resistance due
to bradykinin was suggested to be mediated by an endothelial-
dependent mechanism (Hoagland et al., 1999).
In support of this, Abdulla et al. (2016) investigated the
role of renal bradykinin receptors in the modulation of the
baroreflex in a cisplatin-induced renal failure model. Blockade
of B2 bradykinin receptors, but not B1 receptors, markedly
restored arterial baroreflex regulation of blood pressure in
renal failure rats. In contrast, B1 blockade enhanced the RSNA
sympathoinhibitory response to VE, but blunted this response in
healthy animals (Abdulla et al., 2016). This suggests a possible
role of B1 receptors in mediating a signaling pathway under basal
conditions that maintains the normal baroreflex mechanism.
Similar to the effect of B2 blockade, injection of a specific TRPV1
blocker into the kidney of cisplatin-induced renal failure rats
restored the baroreflex control of RSNA indicating an important
contribution of TRPV1 in mediating an aberrant response from
the injured kidney leading to blunted baroreflex control (Abdulla
et al., Unpublished Data). Together, these studies support the
presence of an excitatory reno-renal reflex that is activated with
contributions from a number of receptors such as TRPV1 and
bradykinin. Similarly, inflammatory mediators such as TNF-α
and IL-6 were found to be highly expressed in the kidney in
models of renal injury and hypertension including exposures
to CIH (Hall et al., 2014; Wu X. et al., 2016; Lu et al.,
2017b) indicating a possible role of these mediators in initiating
a sympathoexcitatory response leading to impaired blood
pressure homeostasis.
Other candidates such as NMDA receptors are expressed in
the renal afferent neurons (Figure 1). Ma et al. (2008) reported
that activation of these receptors by the amino acid D-serine or by
an increase in intra-pelvic pressure initiates an inhibitory reno-
renal reflex response by increasing ARNA. Although this study
provided evidence for an important role of NMDA receptors in
mediating an afferent renal nerve-dependent response, the exact
signaling pathway throughwhich this response is mediated under
normal or diseased states is not fully understood.
RENAL AFFERENT NERVES
AND HYPERTENSION
Dysregulated autonomic control of blood pressure is recognized
as an important component in the pathogenesis of different
models of hypertension including two-kidney one clip Goldblatt
model (Kumagai et al., 1990), SHR (Janssen et al., 1989), high
fat diet-induced hypertension (Khan et al., 2015), and CIH-
induced hypertension (Zoccal et al., 2009a; Shell et al., 2016).
In these models, it was reported that high blood pressure is
associated with sympathetic over-activity leading to peripheral
vasoconstriction, renin release, and sodium and water retention.
In the CIH model for example, a neurogenic mechanism is
activated early in the disease process and is dependent on
increased sympathetic tone (Sharpe et al., 2013). It is not known,
however, if renal afferent signaling has a contributory role in
mediating increased sympathetic nerve activity in CIH and
OSAS. Of interest and relevance, renal denervation was found to
ameliorate hypertension in sleep apnoea syndrome (Witkowski
et al., 2011; Kario et al., 2016a; Keiko et al., 2017). Further
investigation of reno-renal mechanisms as potential contributors
to hypertension in the various models is required.
The baroreflex is impaired in several models of hypertension
including some CIH models (Lai et al., 2006; Yamamoto
et al., 2013). Short-term changes in blood pressure normally
stimulate arterial (high pressure) and to some extent the
cardiopulmonary (low pressure) stretch-sensitive baroreceptors.
These receptors relay afferent signals to the brainstem to
modulate sympathetic and parasympathetic nervous output. The
central mechanism involved in the modulation of the autonomic
response is dependent on functional renin-angiotensin and NO
systems (Abdulla and Johns, 2013, 2014). Indeed, failure of the
baroreflex mechanism is associated with long-term elevation
of resting sympathetic nervous activity, which eventually leads
to hypertension (Hart and Charkoudian, 2014). Kidney injury,
through a reno-renal reflex mechanism, causes a blunted
baroreflex through excessive sympathetic over-activity, which
eventually leads to blood pressure elevation. In different models
of hypertension, it was reported that impairment of the normal
baroreflex mechanism is secondary to afferent renal nerve
activation. Renal afferent nerve hyperactivity is associated with
derangement of reno-renal reflex control, contributing to blood
pressure elevation by suppression of the inhibitory reflex and/or
activation of the excitatory reflex. This notion is supported
by studies showing that suppression of the reno-renal reflex
is involved in the pathogenesis of hypertension in SHR while
activation of the excitatory reflex is proposed to play a major role
in renovascular hypertension and hypertension associated with
chronic kidney disease and obesity (Wyss et al., 1986; Janssen
et al., 1989; Campese and Kogosov, 1995; Khan et al., 2015).
In the SHR model, elevation of peripheral sympathetic nerve
activity is eliminated when the injured kidney is denervated
(Kopp et al., 1998a) with almost a 50% decrease in blood pressure
observed 10min after denervation. Denervation is associated
with a decrease in renal cortical tissue NE (Gao et al., 2016).
Therefore, it has been suggested that part of the blood pressure
lowering effect of renal denervation is due to a decrease in NE
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release from the postganglionic efferent nerves. However, it is
also suggested that the decrease in blood pressure following
denervation is due to interruption of renal afferent neuronal
signaling. Janssen et al. (1989) used selective renal afferent nerve
denervation to demonstrate the significant influence of renal
afferents on SNS activity and baroreflex sensitivity in SHR. Renal
afferent denervation in the latter study did not elicit a blood
pressure lowering effect, and had no effect on urine volume or
sodium excretion. Relevant to these findings, an increase in renal
pelvic pressure or an intra-pelvic injection of bradykinin neither
caused an increase in ARNA, nor an increase in SP release (Kopp
and Smith, 1996; Kopp et al., 1998a). Moreover, there was a
decreased responsiveness of NK 1 receptors to SP in SHR (Kopp
et al., 1998a). These studies provide evidence for suppression
of the inhibitory reno-renal reflex in SHR, which contributes to
sympathetic over-stimulation in this model. Therefore, it appears
that the blood pressure lowering effect of renal denervation in
the SHR model is due to interruption of ERSNA and not related
to afferent nerves.
In another model of hypertension, the two-kidney one
clip model of hypertension, the clipped kidney undergoes
ischaemic damage compared with the non-clipped kidney. Renal
denervation of the non-clipped kidney induced a decrease in
sodium excretion. In contrast, renal denervation of the clipped
kidney resulted in an increase in ipsilateral and contralateral
natriuresis along with a fall in contralateral ERSNA (Kopp and
Buckley-Bleiler, 1989). Likewise, dorsal rhizotomy followed by
clipping of the renal artery resulted in a significant partial
decrease in blood pressure in the one-kidney one clip model.
However, contralateral dorsal rhizotomy of the nephrectomised
kidney did not cause any change in blood pressure (Wyss
et al., 1986). This confirms the presence of excitatory afferent
signals from the clipped kidney that underwent ischaemic insult.
Previous studies suggested that ischemia induces adenosine
release, which in turn stimulates afferent nerves (Liem et al.,
2002). It is possible based on these studies that adenosine, being
an ischaemic mediator, is associated with the activation of renal
chemoreceptors (Ashton et al., 1994). In the one-kidney one clip
model, it was found that blood pressure attenuation following
denervation was not accompanied by an increase in diuresis
and natriuresis (Katholi et al., 1981). Thus, sodium retention
is a feature in the development of hypertension in this model,
but it does not contribute significantly to the mechanism of the
decrease in blood pressure after denervation. Based on these
studies, it is possible that blood pressure reduction is attributed
to an interruption of renal afferents, in addition to the effect of
removal of efferent nerves to the kidneys.
Studies of cisplatin-induced renal injury and a high-fat diet
model of obesity in rats demonstrated that it is the excitatory
reno-renal reflex that is dominant in these models, responsible
for blunted baroreflex control of blood pressure (Khan et al.,
2014, 2017). In obese rats, for example, baroreflex sensitivity of
RSNA and heart rate was blunted, in addition to a significant
decrease in reflex sympathoinihibiton normally elicited by
activation of the cardiopulmonary receptors in response to VE
(Armitage et al., 2012; Khan et al., 2015). The dysregulation of
the baroreflex in cisplatin or high-fat diet models is attributed
to renal inflammation that initiates excitatory afferent neural
signals, a suggestion supported by the increase in renal and
systemic inflammatory cytokines such as TNF-α and interleukin-
6 (IL-6) (Khan et al., 2017). Similarly, transforming growth factor
β1 (TGF-β1) was found to be elevated in renal tissue of the
cisplatin-induced injury model, which was abolished following
bilateral renal denervation (Goulding and Johns, 2015). The
interaction between the immune system response in renal injury
and renal afferent signaling mechanisms was highlighted in a
study of obese rats treated with tacrolimus, an anti-inflammatory
agent (Khan et al., 2017). In this study, suppression of the
immune system restored the low- and high-pressure baroreflex.
In addition, the renal tissue levels of TNF-α and IL-6 were
reduced in these rats. However, dorsal rhizotomy of renal nerves
did not decrease blood pressure in obese dogs (Hall et al.,
2000). A study by Ditting et al. (2016) suggested that renal
afferent excitability is decreased in the presence of chemokines,
in particular, by CXCL2 (Ditting et al., 2016). Therefore, the
contribution of inflammation to the sensitivity of renal afferent
nerves is still not fully understood. Together, the involvement
of renal nerves in mediating the derangement of the baroreflex
control of blood pressure in these studies was evident when
bilateral renal denervation restored the sensitivity of low- and
high-pressure baroreflexes to changes in blood volume and blood
pressure, respectively.
The effect of renal deafferentation was also studied in the 5/6
nephrectomy model and was shown to attenuate hypertension
and decrease NE turnover in the brain (Campese and Kogosov,
1995). Moreover, renal afferent denervation decreased forebrain
Ang II, AT1 receptors, c-fos in RVLM and tyrosine hydroxylase
levels. Similarly, at the level of the kidney, macrophage count,
fibrosis markers and NOX expression were reduced following
denervation (Cao et al., 2015). In deoxycorticosterone acetate
(DOCA) hypertensive rats, renal denervation attenuated arterial
blood pressure by 50% together with a decrease in plasma
NE. Interestingly, the same effect was observed after selective
afferent denervation using capsaicin. Importantly, renal afferent
denervation was performed prior to DOCA initiation which
supports a key role for afferent nerves in the development of
hypertension in this model (Foss et al., 2015). In the latter study,
renal afferent denervation caused a significant decrease in the
renal content of CGRP, with no effect on renal NE levels. This
suggests that the renal afferents play a greater role than renal
efferent nerves in this anti-hypertensive effect. TRPV1 is present
on renal afferent nerve endings and is reported to mediate an
increase in afferent nerve activity via SP. DOCA salt treatment in
TRPV1-null mice showed exaggerated renal damage compared
with wild-type mice in terms albuminuria, glomerulosclerosis,
tubulointerstitial fibrosis and macrophage infiltration, yet blood
pressure was equivalent between the two groups (Wang et al.,
2008). This suggests a potentially key role for TRPV1 in initiating
a renal afferent nerve-dependent response leading to increased
blood pressure.
Ischemic reperfusion injury is another disease model
associated with elevated blood pressure and heart rate. In this
model, oxidative stress and inflammatory cytokines are elevated
in the systemic circulation, SFO, hippocampus, corpus callosum
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and cerebral cortex. Overexpression of NOX2 and NOX4 in
the kidney, SFO and hippocampus was reported in this model
(Simone et al., 2014; Karim et al., 2015; Cao et al., 2017). In a
renal ischemia reperfusion injury model, intracerebroventricular
administration of tempol, losartan, and intra-renal capsaicin
decreased blood pressure, and renal and central oxidative and
inflammatory mediators (Cao et al., 2017). Ma et al. (2002)
reported an impaired release of SP and downregulation of NK1
receptors in the post-ischaemic kidney. In the latter study,
selective stimulation of mechanoreceptors by an increase in
intra-pelvic pressure blunted the inhibitory reno-renal reflex
and impaired renal excretory function. It can be suggested from
the above studies that ischemia as characterized by increased
adenosine and NOX, activates chemoreceptors in the kidney,
which contribute to the enhanced sympathetic activity seen
in hypertension.
RENAL OXIDATIVE STRESS,
INFLAMMATION AND
CIH-INDUCED HYPERTENSION
Inflammation plays a major role in the pathogenesis of CIH-
induced hypertension as reported by a number of studies (Sun
et al., 2012; Iturriaga et al., 2015; Lu et al., 2017b; Abuyassin
et al., 2018). In response to oxidative stress, HIF-1 stimulates
the translocation of nuclear factor kappa B (NF-κB), which
increases the expression of genes that encode TNF-α, interleukin
1β (IL-1β) and IL-6 (Del Rio et al., 2012; Iturriaga et al., 2015;
Oyarce and Iturriaga, 2018). Chronic treatment with ibuprofen
decreased cytokine levels in CIH-exposed carotid bodies, and
attenuated the enhanced ventilatory response to hypoxia and
prevented the development of hypertension (Del Rio et al.,
2012). An anti-inflammatory treatment was associated with a
decrease in c-fos levels in the NTS indicating a role for cytokines
in neurogenic hypertension, in agreement with a number of
previous reports (Sriramula et al., 2008; Kang et al., 2009;
Shi et al., 2010; Del Rio et al., 2012). However, ibuprofen
failed to decrease 3-nitrotyrosine levels and did not impede
the augmented sensitivity of the carotid bodies to hypoxia (Del
Rio et al., 2012). Meanwhile, anti-oxidant treatment abolished
enhanced responsiveness of peripheral chemoreceptors and the
ventilatory response to hypoxia along with a decrease in cytokine
levels in carotid bodies (Del Rio et al., 2012). Thus, it is likely
that inflammation and increased cytokine levels are secondary
to an oxidative stress mechanism in the vasculature associated
with exposure to CIH. In support of this argument, the NLRP3
inflammasome was found to be activated in renal tissue of CIH-
exposed animals, which is well-known to be stimulated by ROS
(Wu et al., 2018). NLPR3 is involved in the activation of caspase-
1 and maturation of IL-1β, which is found to be elevated in
the kidney of CIH-exposed animals. It was suggested that miR-
155 gene inhibition suppresses ROS generation responsible for
NLRP3 activation and subsequently IL-1β generation (Wu et al.,
2018). Similar increases in inflammatory and oxidative stress
markers were reported in the kidneys of CIH-exposed animals
as shown by a number of studies in the literature (Table 2).
The increase in ROS is associated with an increase in renal
tissue hypoxia factors including HIF (Ding et al., 2016). It has
been shown that renal denervation and anti-oxidant treatment
significantly decrease renal oxidative stress and blood pressure
in CIH models (Xiang et al., 2010; Keiko et al., 2017; Lu
et al., 2017b). Exposure to IH for 28 days and for 8 weeks was
accompanied by HIF-1 upregulation in renal tissue (Keiko et al.,
2017; Lu et al., 2017b). HIF-1α overexpression was also observed
in NTS and RVLM after exposure to CIH (Peng et al., 2014). HIF-
1α mediates the transcription of erythropoietin to increase the
oxygen carrying capacity of the blood and protects against tissue
hypoxia (Haase, 2006). HIF-1 upregulation is a ROS-dependent
process mediated by NOX. Lu et al. (2017a) reported NOX4
overexpression in the kidney after exposure to CIH accompanied
by a decrease in SOD levels. RSNA and blood pressure were both
reduced when a NOX4 inhibitor was administered (Lu et al.,
2017a). In addition, treating CIH-exposed rats with N-acetyl
cysteine restored renal tissue SOD levels and decreased RSNA
and blood pressure (Lu et al., 2017a). Immunohistochemistry
demonstrated the co-localization of TRPV1 channels, NOX4 and
H2O2 in renal sensory neurons (Lin et al., 2015). TRPV1 was
found to be sensitized by H2O2 administration leading to SP
release in renal mechanoreceptors (Lin et al., 2015). The effect
of H2O2 on TRPV1 was inhibited by catalase. Likewise, ROS
were suggested to be involved in mediating TRPV1 signaling
in peripheral sensory nerves as well as in carotid bodies (Kline,
2010; Linley et al., 2012). In addition, increased ROS was
reported in the carotid bodies due to an HIF-1-mediated NOX2
upregulation (Kumar and Prabhakar, 2012). This increase in ROS
was associated with enhanced sympathetic nervous response to
hypoxia. We can therefore propose that ROS might sensitize
TRPV1 and upregulate AT1 receptors leading to a modification
in the afferent nerve activity similar to its role in evoking sLTF
of the carotid bodies following exposure to CIH (Marcus et al.,
2010). This is further supported by studies whereby an elevation
of malonaldehyde and oxidative low-density lipoproteins in
renal tissue was positively correlated with Ang II levels
and systolic blood pressure elevation after exposure to CIH
(Xiang et al., 2010, 2012).
Additionally, metallothionein (MT) knockout mice exhibited
renal fibrosis after 3 weeks of exposure to IH, but 8 weeks
of exposure was needed to induce fibrosis in wild-type mice
(Wu et al., 2015). Furthermore, SOD was downregulated while
NOX2 was overexpressed in the NTS and RVLM after 10 days
of exposure to IH (Peng et al., 2014). When viewed together,
these findings highlight an important interaction between ROS
and sympathoexcitation either at the level of the peripheral
organs (carotid bodies and kidneys) and/or within the higher
control centers.
The role of oxidative stress in mediating the elevation in
blood pressure in CIH can be further demonstrated by a study
showing that elevated ROS centrally was associated with a
decrease in NO levels in the brain (Xu et al., 2004). Normally,
NO controls the responsiveness of arterial and cardiopulmonary
receptors to blood pressure changes (Abdulla and Johns, 2013,
2014). Indeed, impaired baroreflex control was reported in CIH-
exposed rats after 17 days of exposure to IH (Lai et al., 2006).
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Exposure to IH for 7 days was associated with a resetting of
the arterial baroreflex but with no effects on baroreflex gain
(Yamamoto et al., 2013). This agrees with previous reports that
illustrated increased expression of pro-inflammatory cytokines
in some brain regions, but not in the RVLM and NTS (Snyder
et al., 2017). However, exposure to CIH for longer periods was
associated with inflammation in the NTS and RVLM, which
might underpin blunted baroreflex function observed during
the later stages of exposure to CIH (Lai et al., 2006; Oyarce
and Iturriaga, 2018). Bilateral carotid body ablation improved
baroreceptor sensitivity in CIH-exposed rats; however, blunted
baroreflex gain of heart rate was not restored (Del Rio et al.,
2016). This suggests the presence of other aberrant afferent
inputs to the NTS in CIH-exposed rats contributing to blunted
baroreflexes. In contrast, Moraes et al. (2016) reported increased
gain of the high-pressure baroreflex during expiration using
the in situ rat preparation after 10 days of exposure to IH.
This was associated with CIH-mediated respiratory modulation
and enhanced inhibitory responses of RVLM presympathetic
neuronal activity (Moraes et al., 2016). In patients with OSAS and
hypertension, an impaired baroreflex response to hypotension
induced by sodium nitroprusside was reported. Interestingly, a
blunted baroreflex response was seen even when blood pressure
is within the normal range (Carlson et al., 1996), suggesting
that derangements present before the evolution of hypertension.
A full understanding of high-pressure baroreflex function in
CIH-exposed animals has not yet been achieved.
OSAS is a known inflammatory disease that activates
inflammatory signaling molecules in the systemic circulation
and kidney tissue, which can cause renal fibrosis and apoptosis
as indicated by studies of CIH-exposed animals (Adeseun and
Rosas, 2010; Wu X. et al., 2016; Lu et al., 2017a). Exposure to CIH
is associated with elevated expression of the NF-κB transcription
factor in renal tissue and inflammatory cytokines including TNF-
α, IL-6 and IL-1β in renal and blood samples (Wu X. et al.,
2016; Lu et al., 2017b; Snyder et al., 2017; Zhang Y. et al., 2018).
Short-term exposure to IH was sufficient to increase intercellular
adhesion molecule (ICAM) levels (Sun et al., 2012). In addition,
mitogen activated protein kinases enhanced the phosphorylation
of JNK, P38 and ERK1/2 in renal tissue after exposure to CIH
(Wu X. et al., 2016). Chronic kidney disease is often diagnosed
in patients with OSAS. Therefore, molecular mechanisms
underlying OSAS-induced kidney damage are currently of
interest. Renal histopathological damage and inflammatory
cytokines levels were attenuated in NLRP3 inflammasome
knockout mice (Wu et al., 2018). Moreover, NLRP3 knockout
and toll-like receptor 4 (TLR-4) knockout mice had significantly
decreased serum creatinine and blood urea compared with wild-
type CIH-exposed mice (Zhang Y. et al., 2018). TLR-4 deficient
mice expressed fewer renal macrophages, collagen, fibroblast
accumulation, and pro-apoptotic protein Bax expression after
exposure to CIH compared with CIH-exposed wild-type mice.
Importantly, MyD88 and NF-κB p65 expression was significantly
attenuated in CIH-exposed TLR-4 knockout mice. Subsequently,
elevated cytokines such as IL-6, monocyte chemoattractant
protein 1 (MCP-1) and TNF-α, observed in CIH-exposed animals
were alleviated in TLR-4 deficient mice (Zhang Y. et al., 2018).
In another model of renal injury/inflammation, the obese rat
model, it has been shown that sympathoexcitation and blunted
baroreflex regulation was associated with elevated renal tissue
levels of cytokines such as TNF-α and IL-6 (Khan et al., 2017).
Ten days of exposure to IH (6% O2 for 40 s every 9min) in
juvenile male rats was enough to cause hypertension and enhance
the sensitivity of the sympathetic and parasympathetic baroreflex
regulation of blood pressure (Zoccal et al., 2009a). Interestingly,
this suppression of the baroreflex was abolished when renal
denervation was performed or when the immune system was
suppressed pharmacologically in obese rats (Khan et al., 2017).
Therefore, the renal afferent nerves in this model appear to play a
key role in mediating a response from the injured kidney leading
to increased sympathetic nervous activity and blood pressure.
It is suggested that TNF-α and other inflammatory mediators
are involved in blunting of the baroreflex and blood pressure
elevation in OSAS patients. Most importantly, renal denervation
studies in humans with OSAS report a decrease in sympathetic
over-activity and blood pressure indicating a potential role
played by renal nerves in the hypertension of OSAS (Witkowski
et al., 2011; Linz et al., 2012; Zhao et al., 2013). Although
the importance of renal nerves in OSAS-related hypertension
in humans is recognized and a decrease in blood pressure is
observed in patients following renal denervation, the detailed
mechanisms underpinning this effect remain to be carefully
determined. Together, the findings from previous studies suggest
a mechanistic link between oxidative stress, increased production
of cytokines and neural signals originating from the kidney as a
potential driver of CIH-induced hypertension.
Based on previous studies, it appears that exposure to
CIH induces a temporal response such that short-term or
mild IH initiates oxidative and inflammatory signaling during
which cellular defense mechanisms are activated to elicit a
compensatory response (Table 2). However, long-term or severe
IH induces inflammation, apoptosis and a decrease in the levels of
antioxidant and anti-inflammatory enzymes (de-compensatory
response) (Wu et al., 2015; Ding et al., 2016; Wu X. et al., 2016;
Keiko et al., 2017; Lu et al., 2017b; Poonit et al., 2017). Although
some studies reported compensatory responses for up to 3 weeks
of exposure to IH, other studies reported renal morphological
damage and attenuation of antioxidant enzymes after just 2 weeks
of exposure to IH (Poonit et al., 2017).
As shown in Table 2, short-term IH exposure (3 days)
is sufficient to induce lipid peroxidation, release of adhesion
molecules (ICAM-1) and fibrogenetic factors (Sun et al., 2012).
This indicates that IH might induce early renal injury as
indicated by morphological changes and fibrosis (Sun et al., 2012;
Poonit et al., 2017). Contemporaneously, protective antioxidative
enzymes are induced within 3 days of exposure to IH (Sun
et al., 2012). This addresses another issue regarding the cause
of hypertension in OSAS patients. First, exposure to CIH might
induce oxidative stress and inflammation within the kidney,
which causes HIF-1 release and sodium and water retention,
modulating reno-renal reflexes. As a result, the kidney cooperates
with the carotid bodies in the activation of SNS outflow,
evoking hypertension. Second, exposure to CIH stimulates
sympathetic activity via actions on the carotid bodies, which
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FIGURE 2 | Mechanisms associated with the development of hypertension in
chronic intermittent hypoxia (CIH)-exposed animals. Blue lines represent
afferent signals; red lines represent efferent sympathetic discharge; yellow lines
represent mechanisms involved in sensory long-term facilitation (sLTF). A
decrease in the partial pressure of oxygen excites carotid body afferent
discharge to the nucleus tractus solitarius (NTS). Signals are integrated to
activate the rostral ventrolateral medulla (RVLM), increasing sympathetic nerve
activity to different organs including the kidneys. An increase in efferent renal
sympathetic nerve activity (ERSNA) activates the renin-angiotensin-aldosterone
system (RAAS) and increases oxygen demand of the kidney. CIH also exerts
direct and lasting effects on the kidneys. This stimulates afferent renal nerve
signals, which are integrated in the NTS ultimately activating RVLM neurons,
driving a reflex increase in ERSNA and additional release of angiotensin II (Ang
II). Ang II causes vasoconstriction, which further decreases oxygen supply to
the carotid bodies exaggerating their activity. Ang II stimulates
circumventricular organs (CVO) such as the subfornical organ (SFO), which
activates the paraventricular nucleus (PVN) of the hypothalamus enhancing
sympathetic nerve activity. A decrease in renal oxygen levels is associated with
increased secretion of erythropoietin. CIH elaborates a vicious cycle causing
oxidative stress and inflammation in the carotid bodies, kidneys, and brain.
causes blood pressure elevation, NE and Ang II release. This
leads to kidney damage, modulation of reno-renal reflexes with
deleterious consequences for the long-term control of blood
pressure. Herein, we introduce a hypothesis, with supporting
evidence from a range of studies, suggesting a role for renal
afferent signaling in CIH-induced hypertension, with relevance
to human OSAS.
CONCLUSIONS
In CIH, the renal nerves play a key role in mediating
pathophysiological responses, which contribute to derangement
of blood pressure control leading to hypertension. Renal
denervation in hypertensive humans with OSAS leads to a
reduction in sympathetic nervous activity and blood pressure.
Whereas, renal efferent nerves are implicated in kidney injury
and hypertension, renal afferent nerves also play an essential
causal role in sympathetic over-excitation and blood pressure
elevation in various models of renal injury and hypertension.
Exploration of mechanisms underpinning aberrant renal afferent
signaling in experimental models is an area worthy of further
investigation, especially in CIH-induced hypertension models. It
is still unknown whether aberrant renal afferent signals represent
activation of the excitatory reno-renal reflexes as revealed in
a renal failure model, or suppression of inhibitory reno-renal
reflexes as reported in SHR. Downregulation of NK1 receptors
has been observed after exposure to chronic hypoxia, but not
IH (Iacobas et al., 2006). This points to suppression of the
mechanosensitive-mediated inhibitory reno-renal reflex in the
CIH model. However, this does not exclude the possibility
of coincident excitatory reno-renal reflex elevation of blood
pressure, mediated by renal chemoreceptors. Possible mediators
of aberrant renal afferent responses include ET with differential
effects on ET-A (inhibits ARNA) and ET-B receptors (activates
ARNA) under physiological conditions (Kopp et al., 2009). Of
note, ET-A receptors are upregulated in the renal medulla of
CIH-exposed animals (Guo et al., 2013).
We acknowledge and emphasize that renal nerve-mediated
responses are not the sole mechanism of hypertension in CIH,
given the extensive literature revealing the importance of CIH-
induced plasticity in the carotid bodies and central integrative
sites, and respiratory-sympathetic coupling, which contribute
to sympathetic nervous over-activity. There is convincing
evidence that the development of hypertension in the CIH
model is associated with sensitization of the carotid bodies.
Hypertension is maintained even under normoxic conditions
by a sLTF mechanism in the carotid bodies partly mediated
by angiotensin II acting on AT1 receptors. Nevertheless, as
evident by recent studies in guinea-pigs (Docio et al., 2018;
Lucking et al., 2018), which have hypoxia-insensitive carotid
bodies, other mechanisms are also suggested to play a role in the
initiation and maintenance of CIH-induced hypertension, which
we posit may be linked to decreased renal oxygenation and NTS
plasticity (Figure 2).
Experimental protocols of CIH vary considerably (Table 2).
Short-term exposure to IH causes the activation of cellular
defense mechanisms and renal injury. This indicates an early role
for the kidney in blood pressure regulation in disease models.
Long-term exposure to IH induces the release of renal ROS and
inflammatory cytokines, which modulate renal afferent signals
to the NTS. Elevated renal ischaemic mediators can lead to
renal chemoreceptor stimulation, with consequential activation
of the excitatory reno-renal reflex. Exposure to CIH upregulates
receptors such as ET-A receptors, which suppress the inhibitory
reno-renal reflex. Similarly, TRPV1 and bradykinin receptors are
recognized as important regulators of renal sensory signaling in
differentmodels of renal injury. As CIH is a known driver of renal
injury and inflammation, the role of TRPV1 and other receptors
on renal sensory nerve endings represents an important area for
future research to widen our understanding of the pathogenesis
of hypertension in models of CIH-induced hypertension, with
implications for human sleep-disordered breathing.
AUTHOR CONTRIBUTIONS
SA wrote the manuscript. MA and KO edited and revised and
manuscript. All authors revised and approved the final version.
Frontiers in Physiology | www.frontiersin.org 19 April 2019 | Volume 10 | Article 465
AlMarabeh et al. Renal Afferent Nerves and CIH-Induced Hypertension
REFERENCES
Abdel-Kader, K., Dohar, S., Shah, N., Jhamb, M., Reis, S. E., Strollo, P., et al. (2012).
Resistant hypertension and obstructive sleep apnea in the setting of kidney
disease. J. Hypertens. 30, 960–966. doi: 10.1097/HJH.0b013e328351d08a
Abdulla, M. H., Duff, M., Swanton, H., and Johns, E. J. (2016). Bradykinin
receptor blockade restores the baroreflex control of renal sympathetic nerve
activity in cisplatin-induced renal failure rats. Acta Physiol. 218, 212–224.
doi: 10.1111/apha.12801
Abdulla, M. H., and Johns, E. J. (2013). Role of angiotensin AT2 receptors
and nitric oxide in the cardiopulmonary baroreflex control of renal
sympathetic nerve activity in rats. J. Hypertens. 31, 1837–1846.
doi: 10.1097/HJH.0b013e3283622198
Abdulla, M. H., and Johns, E. J. (2014). Nitric oxide impacts on angiotensin
AT2 receptor modulation of high-pressure baroreflex control of renal
sympathetic nerve activity in anaesthetized rats. Acta. Physiol. 210, 832–844.
doi: 10.1111/apha.12207
Abdulla, M. H., and Johns, E. J. (2017). The innervation of the kidney in renal
injury and inflammation: a cause and consequence of deranged cardiovascular
control. Acta. Physiol. 220, 404–416. doi: 10.1111/apha.12856
Abuyassin, B., Badran, M., Ayas, N. T., and Laher, I. (2018). Intermittent hypoxia
causes histological kidney damage and increases growth factor expression
in a mouse model of obstructive sleep apnea. PLoS ONE 13:e0192084.
doi: 10.1371/journal.pone.0192084
Accorsi-Mendonça, D., and Machado, B. H. (2013). Synaptic transmission of
baro- and chemoreceptors afferents in the NTS second order neurons. Auton.
Neurosci. 175, 3–8. doi: 10.1016/j.autneu.2012.12.002
Adeseun, G. A., and Rosas, S. E. (2010). The impact of obstructive sleep
apnea on chronic kidney disease. Curr. Hypertens. Rep. 12, 378–383.
doi: 10.1007/s11906-010-0135-1
Affleck, V. S., Coote, J. H., and Pyner, S. (2012). The projection and synaptic
organisation of NTS afferent connections with presympathetic neurons, GABA
and nNOS neurons in the paraventricular nucleus of the hypothalamus.
Neuroscience 219, 48–61. doi: 10.1016/j.neuroscience.2012.05.070
Ahmad, M., Makati, D., and Akbar, S. (2017). Review of and updates on
hypertension in obstructive sleep apnea. Int. J. Hypertens. 2017:1848375.
doi: 10.1155/2017/1848375
Almado, C. E., Machado, B. H., and Leão, R. M. (2012). Chronic intermittent
hypoxia depresses afferent neurotransmission in NTS neurons by a
reduction in the number of active synapses. J. Neurosci. 32, 16736–16746.
doi: 10.1523/JNEUROSCI.2654-12.2012
Anderson, E. A., Sinkey, C. A., Lawton, W. J., and Mark, A. L. (1989).
Elevated sympathetic nerve activity in borderline hypertensive humans.
Evidence from direct intraneural recordings. Hypertension 14, 177–183.
doi: 10.1161/01.HYP.14.2.177
Andrade, D. C., Toledo, C., Diaz, H., Haine, L., Quintanilla, R. A., Marcus,
N. J., et al. (2018). Ventilatory and autonomic regulation in sleep apnea
syndrome: a potential protective role for erythropoietin? Front. Physiol. 9:1440.
doi: 10.3389/fphys.2018.01440
Armitage, J. A., Burke, S. L., Prior, L. J., Barzel, B., Eikelis, N., Lim, K., et al. (2012).
Rapid onset of renal sympathetic nerve activation in rabbits fed a high-fat diet.
Hypertension 60, 163–171. doi: 10.1161/HYPERTENSIONAHA.111.190413
Aroor, A. R., Demarco, V. G., Jia, G., Sun, Z., Nistala, R., Meininger, G.
A., et al. (2013). The role of tissue Renin-Angiotensin-aldosterone system
in the development of endothelial dysfunction and arterial stiffness. Front.
Endocrinol. 4:161. doi: 10.3389/fendo.2013.00161
Ashton, N., Clarke, C. G., Eddy, D. E., and Swift, F. V. (1994). Mechanisms
involved in the activation of ischemically sensitive, afferent renal nerve
mediated reflex increases in hind-limb vascular resistance in the anesthetized
rabbit. Can. J. Physiol. Pharmacol. 72, 637–643. doi: 10.1139/y94-090
Badran, M., Abuyassin, B., Golbidi, S., Ayas, N., and Laher, I. (2016). Uncoupling
of vascular nitric oxide synthase caused by intermittent hypoxia. Oxid. Med.
Cell. Longev. 2016:2354870. doi: 10.1155/2016/2354870
Baltzis, D., Bakker, J. P., Patel, S. R., and Veves, A. (2016). Obstructive sleep apnea
and vascular diseases.Compr. Physiol. 6, 1519–1528. doi: 10.1002/cphy.c150029
Bao, G., Metreveli, N., Li, R., Taylor, A., and Fletcher, E. C. (1997). Blood pressure
response to chronic episodic hypoxia: role of the sympathetic nervous system.
J. Appl. Physiol. 83, 95–101. doi: 10.1152/jappl.1997.83.1.95
Barnett, W. H., Abdala, A. P., Paton, J. F., Rybak, I. A., Zoccal, D. B., and Molkov,
Y. I. (2017). Chemoreception and neuroplasticity in respiratory circuits. Exp.
Neurol. 287(Pt 2), 153–164. doi: 10.1016/j.expneurol.2016.05.036
Barry, E. F., and Johns, E. J. (2015). Intrarenal bradykinin elicits reno-renal reflex
sympatho-excitation and renal nerve-dependent fluid retention. Acta. Physiol.
213, 731–739. doi: 10.1111/apha.12420
Booth, L. C., May, C. N., and Yao, S. T. (2015a). The role of the renal
afferent and efferent nerve fibers in heart failure. Front. Physiol. 6:270.
doi: 10.3389/fphys.2015.00270
Booth, L. C., Nishi, E. E., Yao, S. T., Ramchandra, R., Lambert, G. W., Schlaich,
M. P., et al. (2015b). Reinnervation of renal afferent and efferent nerves at 5.5
and 11 months after catheter-based radiofrequency renal denervation in sheep.
Hypertension. 65, 393–400. doi: 10.1161/HYPERTENSIONAHA.114.04176
Braga, V. A., Soriano, R. N., and Machado, B. H. (2006). Sympathoexcitatory
response to peripheral chemoreflex activation is enhanced in juvenile rats
exposed to chronic intermittent hypoxia. Exp. Physiol. 91, 1025–1031.
doi: 10.1113/expphysiol.2006.034868
Calaresu, F. R., Stella, A., and Zanchetti, A. (1976). Haemodynamic responses and
renin release during stimulation of afferent renal nerves in the cat. J. Physiol.
255, 687–700. doi: 10.1113/jphysiol.1976.sp011303
Calhoun, D. A. (2010). Obstructive sleep apnea and hypertension. Curr. Hyperten.
Rep. 12, 189–195. doi: 10.1007/s11906-010-0112-8
Campese, V. M., and Kogosov, E. (1995). Renal afferent denervation prevents
hypertension in rats with chronic renal failure. Hypertension 25, 878–882.
doi: 10.1161/01.HYP.25.4.878
Cao, W., Li, A., Li, J., Wu, C., Cui, S., Zhou, Z., et al. (2017). Reno-cerebral reflex
activates the renin-angiotensin system, promoting oxidative stress and renal
damage after ischemia-reperfusion injury.Antioxid. Redox. Signal. 27, 415–432.
doi: 10.1089/ars.2016.6827
Cao, W., Li, A., Wang, L., Zhou, Z., Su, Z., Bin, W., et al. (2015). A salt-
induced reno-cerebral reflex activates renin-angiotensin systems and promotes
CKD progression. J. Am. Soc. Nephrol. 26, 1619–1633. doi: 10.1681/ASN.
2014050518
Carlson, J. T., Hedner, J. A., Sellgren, J., Elam, M., and Wallin, B. G. (1996).
Depressed baroreflex sensitivity in patients with obstructive sleep apnea. Am.
J. Respir. Crit. Care Med. 154, 1490–1496. doi: 10.1164/ajrccm.154.5.8912770
Coelho, N. R., Dias, C. G., João Correia, M., Grácio, P., Serpa, J., Monteiro, E. C.,
et al. (2018). Cysteine oxidative dynamics underlies hypertension and kidney
dysfunction induced by chronic intermittent hypoxia. Adv. Exp. Med. Biol.
1071, 83–88. doi: 10.1007/978-3-319-91137-3_10
Coleman, C. G., Wang, G., Park, L., Anrather, J., Delagrammatikas, G. J.,
Chan, J., et al. (2010). Chronic intermittent hypoxia induces NMDA
receptor-dependent plasticity and suppresses nitric oxide signaling in the
mouse hypothalamic paraventricular nucleus. J. Neurosci. 30, 12103–12112.
doi: 10.1523/JNEUROSCI.3367-10.2010
Costa-Silva, J. H., Zoccal, D. B., and Machado, B. H. (2012). Chronic intermittent
hypoxia alters glutamatergic control of sympathetic and respiratory activities in
the commissural NTS of rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 302,
R785–R793. doi: 10.1152/ajpregu.00363.2011
Daniels, F., De Freitas, S., Smyth, A., Garvey, J., Judge, C., Gilmartin, J. J. et al.
(2017). Effects of renal sympathetic denervation on blood pressure, sleep
apnoea severity and metabolic indices: a prospective cohort study. Sleep Med.
30, 180–184. doi: 10.1016/j.sleep.2016.09.014
Del Rio, R., Andrade, D. C., Lucero, C., Arias, P., and Iturriaga, R.
(2016). Carotid body ablation abrogates hypertension and autonomic
alterations induced by intermittent hypoxia in rats. Hypertension 68, 436–445.
doi: 10.1161/HYPERTENSIONAHA.116.07255
Del Rio, R., Moya, E. A., Parga, M. J., Madrid, C., and Iturriaga, R. (2012). Carotid
body inflammation and cardiorespiratory alterations in intermittent hypoxia.
Eur. Respir. J. 39, 1492–1500. doi: 10.1183/09031936.00141511
Ding, W., Cai, Y., Wang, W., Ji, L., Dong, Y., Zhang, X., et al. (2016). Adiponectin
protects the kidney against chronic intermittent hypoxia-induced injury
through inhibiting endoplasmic reticulum stress. Sleep Breath 20, 1069–1074.
doi: 10.1007/s11325-016-1321-4
Ditting, T., Freisinger, W., Rodionova, K., Schatz, J., Lale, N., Heinlein, S., et al.
(2016). Impaired excitability of renal afferent innervation after exposure to the
inflammatory chemokine CXCL1. Am. J. Physiol. Renal Physiol. 310, F364–
F371. doi: 10.1152/ajprenal.00189.2015
Frontiers in Physiology | www.frontiersin.org 20 April 2019 | Volume 10 | Article 465
AlMarabeh et al. Renal Afferent Nerves and CIH-Induced Hypertension
Docio, I., Olea, E., Prieto-LLoret, J., Gallego-Martin, T., Obeso, A., Gomez-
Niño, A., et al. (2018). Guinea pig as a model to study the carotid
body mediated chronic intermittent hypoxia effects. Front. Physiol. 9:694.
doi: 10.3389/fphys.2018.00694
Emans, T. W., Janssen, B. J., Pinkham, M. I., Ow, C. P., Evans, R. G., Joles, J. A.,
et al. (2016). Exogenous and endogenous angiotensin-II decrease renal cortical
oxygen tension in conscious rats by limiting renal blood flow. J. Physiol. 594,
6287–6300. doi: 10.1113/JP270731
Feng, N. H., Lee, H. H., Shiang, J. C., and Ma, M. C. (2008). Transient
receptor potential vanilloid type 1 channels act as mechanoreceptors and cause
substance P release and sensory activation in rat kidneys. Am. J. Physiol. Renal.
Physiol. 294, F316–F325. doi: 10.1152/ajprenal.00308.2007
Ferreira, C. B., Cravo, S. L., and Stocker, S. D. (2018). Airway obstruction produces
widespread sympathoexcitation: role of hypoxia, carotid chemoreceptors, and
NTS neurotransmission. Physiol. Rep. 6. doi: 10.14814/phy2.13536
Fletcher, E. C., Bao, G., and Li, R. (1999). Renin activity and blood
pressure in response to chronic episodic hypoxia. Hypertension 34, 309–314.
doi: 10.1161/01.HYP.34.2.309
Fletcher, E. C., Lesske, J., Behm, R., Miller, C. C. III, Stauss, H., and Unger,
T. (1992). Carotid chemoreceptors, systemic blood pressure, and chronic
episodic hypoxia mimicking sleep apnea. J. Appl. Physiol. 72, 1978–1984.
doi: 10.1152/jappl.1992.72.5.1978
Foss, J. D.,Wainford, R. D., Engeland,W. C., Fink, G. D., and Osborn, J.W. (2015).
A novel method of selective ablation of afferent renal nerves by periaxonal
application of capsaicin. Am. J. Physiol. Regul. Integr. Comp. Physiol. 308,
R112–R122. doi: 10.1152/ajpregu.00427.2014
Gao, J., Kerut, E. K., Smart, F., Katsurada, A., Seth, D., Navar, L. G., and Kapusta,
D. R. (2016). Sympathoinhibitory effect of radiofrequency renal denervation
in spontaneously hypertensive rats with established hypertension. Am. J.
Hypertens. 29, 1394–1401. doi: 10.1093/ajh/hpw089
Gilmartin, G. S., Lynch, M., Tamisier, R., and Weiss, J. W. (2010). Chronic
intermittent hypoxia in humans during 28 nights results in blood pressure
elevation and increasedmuscle sympathetic nerve activity.Am. J. Physiol. Heart
Circ. Physiol. 299, H925–H931. doi: 10.1152/ajpheart.00253.2009
Gjørup, P. H., Sadauskiene, L., Wessels, J., Nyvad, O., Strunge, B., and Pedersen,
E. B. (2007). Abnormally increased endothelin-1 in plasma during the night in
obstructive sleep apnea: relation to blood pressure and severity of disease. Am.
J. Hypertens. 20, 44–52. doi: 10.1016/j.amjhyper.2006.05.021
Gjørup, P. H., Wessels, J., and Pedersen, E. B. (2008). Abnormally increased
nitric oxide synthesis and increased endothelin-1 in plasma in patients
with obstructive sleep apnoea. Scand. J. Clin. Lab. Invest. 68, 375–385.
doi: 10.1080/00365510701782382
Gontijo, J. A., and Kopp, U. C. (1999). Activation of renal pelvic chemoreceptors in
rats: role of calcitonin gene-related peptide receptors. Acta Physiol. Scand. 166,
159–165. doi: 10.1046/j.1365-201x.1999.00540.x
Gontijo, J. R., and Kopp, U. C. (1994). Renal sensory receptor activation
by calcitonin gene-related peptide. Hypertension 23(6 Pt 2), 1063–1067.
doi: 10.1161/01.HYP.23.6.1063
Goodwill, V. S., Terrill, C., Hopewood, I., Loewy, A. D., and Knuepfer, M. M.
(2017). CNS sites activated by renal pelvic epithelial sodium channels (ENaCs)
in response to hypertonic saline in awake rats. Auton. Neurosci. 204, 35–47.
doi: 10.1016/j.autneu.2016.09.015
Gottlieb, D. J., Yenokyan, G., Newman, A. B., O’Connor, G. T., Punjabi, N. M.,
Quan, S. F., et al. (2010). Prospective study of obstructive sleep apnea and
incident coronary heart disease and heart failure: the sleep heart health study.
Circulation 122, 352–360. doi: 10.1161/CIRCULATIONAHA.109.901801
Goulding, N. E., and Johns, E. J. (2015). Neural regulation of the kidney
function in rats with cisplatin induced renal failure. Front. Physiol. 6:192.
doi: 10.3389/fphys.2015.00192
Guo, Q. H., Tian, Y. L., Wang, Z., Li, A. Y., Ma, Z. H., Guo, Y. J., et al. (2013).
Endothelin receptors in augmented vasoconstrictor responses to endothelin-
1 in chronic intermittent hypoxia. Clin. Exp. Pharmacol. Physiol. 40, 449–457.
doi: 10.1111/1440-1681.12109
Guyton, A. (2010). Role of the Kidney in Long Term Regulation of Blood Pressure.
Guyton and Hall Textbook of Medical Physiology. 12th Edn. St. Louis, MO:
Saunders.
Haase, V. H. (2006). Hypoxia-inducible factors in the kidney. Am. J. Physiol. Renal
Physiol. 291, F271–F281. doi: 10.1152/ajprenal.00071.2006
Hall, J. E. (1994). Louis K. Dahl memorial lecture. Renal and cardiovascular
mechanisms of hypertension in obesity. Hypertension 23, 381–394.
doi: 10.1161/01.HYP.23.3.381
Hall, J. E., Brands, M. W., Hildebrandt, D. A., Kuo, J., and Fitzgerald, S. (2000).
Role of sympathetic nervous system and neuropeptides in obesity hypertension.
Braz. J. Med. Biol. Res. 33, 605–618. doi: 10.1590/S0100-879X2000000600001
Hall, M. E., do Carmo, J. M., da Silva, A. A., Juncos, L. A., Wang, Z., and Hall, J.
E. (2014). Obesity, hypertension, and chronic kidney disease. Int. J. Nephrol.
Renovasc. Dis. 7, 75–88. doi: 10.2147/IJNRD.S39739
Hart, E. C., and Charkoudian, N. (2014). Sympathetic neural regulation
of blood pressure: influences of sex and aging. Physiology 29, 8–15.
doi: 10.1152/physiol.00031.2013
Hindermann, M., Martin, T., Rodionova, K., Loosen, S., Ott, C., Schmieder, R.
E., et al. (2017). Effects of intrarenal afferent stimulation by bradykinin on
renal sympathetic nerve activity: tonic inhibition facilitating sodium and water
excretion. FASEB J. 31(1_suppl.), 1027–2.
Hoagland, K. M., Maddox, D. A., and Martin, D. S. (1999). Bradykinin
B2-receptors mediate the pressor and renal hemodynamic effects of
intravenous bradykinin in conscious rats. J. Auton. Nerv Syst. 75, 7–15.
doi: 10.1016/S0165-1838(98)00166-0
Huang, J., Lusina, S., Xie, T., Ji, E., Xiang, S., Liu, Y., and Weiss, J. W.
(2009). Sympathetic response to chemostimulation in conscious rats exposed
to chronic intermittent hypoxia. Respir Physiol. Neurobiol. 166, 102–106.
doi: 10.1016/j.resp.2009.02.010
Huang, J., Xie, T.,Wu, Y., Li, X., Lusina, S., Ji, E. S., et al. (2010). Cyclic intermittent
hypoxia enhances renal sympathetic response to ICV ET-1 in conscious rats.
Respir. Physiol. Neurobiol. 171, 83–89. doi: 10.1016/j.resp.2010.03.008
Iacobas, D. A., Fan, C., Iacobas, S., Spray, D. C., and Haddad, G. G. (2006).
Transcriptomic changes in developing kidney exposed to chronic hypoxia.
Biochem. Biophys. Res. Commun. 349, 329–338. doi: 10.1016/j.bbrc.2006.08.056
Iturriaga, R., Moya, E. A., andDel Rio, R. (2015). Inflammation and oxidative stress
during intermittent hypoxia: the impact on chemoreception. Exp. Physiol. 100,
149–155. doi: 10.1113/expphysiol.2014.079525
Janssen, B. J., van Essen, H., Vervoort-Peters, L. H., Struyker-Boudier, H. A., and
Smits, J. F. (1989). Role of afferent renal nerves in spontaneous hypertension in
rats. Hypertension 13, 327–333. doi: 10.1161/01.HYP.13.4.327
Javaheri, S., and Dempsey, J. A. (2013). Central sleep apnea. Compr Physiol. 3,
141–163. doi: 10.1002/cphy.c110057
Johns, E. J., Kopp, U. C., andDiBona, G. F. (2011). Neural control of renal function.
Compr. Physiol. 1, 731–767. doi: 10.1002/cphy.c100043
Kanagy, N. L. (2009). Vascular effects of intermittent hypoxia. ILAR. J. 50, 282–288.
doi: 10.1093/ilar.50.3.282
Kang, Y. M., Ma, Y., Zheng, J. P., Elks, C., Sriramula, S., Yang, Z. M., et al.
(2009). Brain nuclear factor-kappa B activation contributes to neurohumoral
excitation in angiotensin II-induced hypertension. Cardiovasc. Res. 82,
503–512. doi: 10.1093/cvr/cvp073
Karim, A. S., Reese, S. R., Wilson, N. A., Jacobson, L. M., Zhong, W., and Djamali,
A. (2015). Nox2 is a mediator of ischemia reperfusion injury.Am. J. Transplant.
15, 2888–2899. doi: 10.1111/ajt.13368
Kario, K., Bhatt, D. L., Kandzari, D. E., Brar, S., Flack, J. M., Gilbert, C., et al.
(2016a). Impact of renal denervation on patients with obstructive sleep apnea
and resistant hypertension- insights from the SYMPLICITY HTN-3 Trial. Circ.
J. 80, 1404–1412. doi: 10.1253/circj.CJ-16-0035
Kario, K., Ikemoto, T., Kuwabara, M., Ishiyama, H., Saito, K., and Hoshide,
S. (2016b). Catheter-based renal denervation reduces hypoxia-triggered
nocturnal blood pressure peak in obstructive sleep apnea syndrome. J. Clin.
Hypertens. 18, 707–709. doi: 10.1111/jch.12759
Katholi, R. E., Winternitz, S. R., and Oparil, S. (1981). Role of the renal nerves in
the pathogenesis of one-kidney renal hypertension in the rat. Hypertension 3,
404–409. doi: 10.1161/01.HYP.3.4.404
Kawada, T., Shimizu, S., Kamiya, A., Sata, Y., Uemura, K., and Sugimachi,
M. (2011). Dynamic characteristics of baroreflex neural and peripheral
arcs are preserved in spontaneously hypertensive rats. Am. J. Physiol.
Regul. Integr. Comp. Physiol. 300, R155–R165. doi: 10.1152/ajpregu.0054
0.2010
Keiko, T., Seiji, U., Takashi, K., Akira, N., Takeshi, S., and Yusuke, S. (2017). Renal
sympathetic nerve denervation inhibits chronic intermittent hypoxia-induced
hypertension by decreasing renin-angiotensin system and oxidative stress in
Frontiers in Physiology | www.frontiersin.org 21 April 2019 | Volume 10 | Article 465
AlMarabeh et al. Renal Afferent Nerves and CIH-Induced Hypertension
a mouse model of sleep apnea syndrome. Nephrol. Dial. Transplant. 32:120.
doi: 10.1093/ndt/gfx139.SP046
Khan, S. A., Sattar, M. A., Rathore, H. A., Abdulla, M. H., Ud Din Ahmad,
F., Ahmad, A., et al. (2014). Renal denervation restores the baroreflex
control of renal sympathetic nerve activity and heart rate in Wistar-
Kyoto rats with cisplatin-induced renal failure. Acta Physiol. 210, 690–700.
doi: 10.1111/apha.12237
Khan, S. A., Sattar, M. Z., Abdullah, N. A., Rathore, H. A., Abdulla, M. H., Ahmad,
A., et al. (2015). Obesity depresses baroreflex control of renal sympathetic nerve
activity and heart rate in Sprague Dawley rats: role of the renal innervation.
Acta Physiol. 214, 390–401. doi: 10.1111/apha.12499
Khan, S. A., Sattar, M. Z. A., Abdullah, N. A., Rathore, H. A., Ahmad, A., Abdulla,
M. H., et al. (2017). Improvement in baroreflex control of renal sympathetic
nerve activity in obese sprague dawley rats following immunosuppression.Acta
Physiol. 221, 250–265. doi: 10.1111/apha.12891
Kline, D. D. (2010). Chronic intermittent hypoxia affects integration of sensory
input by neurons in the nucleus tractus solitarii. Respir. Physiol. Neurobiol. 174,
29–36. doi: 10.1016/j.resp.2010.04.015
Knuepfer, M. M., and Schramm, L. P. (1987). The conduction velocities and spinal
projections of single renal afferent fibers in the rat. Brain Res. 435, 167–173.
doi: 10.1016/0006-8993(87)91598-8
Konecny, T., Kara, T., and Somers, V. K. (2014). Obstructive sleep
apnea and hypertension: an update. Hypertension 63, 203–209.
doi: 10.1161/HYPERTENSIONAHA.113.00613
Kopp, U. C. (2011a). Neural Control of Renal Function. San Rafael, CA: Morgan &
Claypool Life Sciences.
Kopp, U. C. (2011b). Endothelin in the control of renal sympathetic nerve activity.
Contrib. Nephrol. 172, 107–119. doi: 10.1159/000328688
Kopp, U. C. (2015). Role of renal sensory nerves in physiological and
pathophysiological conditions.Am. J. Physiol. Regul. Integr. Comp. Physiol. 308,
R79–95. doi: 10.1152/ajpregu.00351.2014
Kopp, U. C., and Buckley-Bleiler, R. L. (1989). Impaired renorenal reflexes
in two-kidney, one clip hypertensive rats. Hypertension 14, 445–452.
doi: 10.1161/01.HYP.14.4.445
Kopp, U. C., Cicha,M. Z., Farley, D.M., Smith, L. A., et al. (1998a). Renal substance
P-containing neurons and substance P receptors impaired in hypertension.
Hypertension 31, 815–822. doi: 10.1161/01.HYP.31.3.815
Kopp, U. C., Cicha, M. Z., and Jones, S. Y. (2010). Activation of endothelin
A receptors contributes to impaired responsiveness of renal mechanosensory
nerves in congestive heart failure. Can. J. Physiol. Pharmacol. 88, 622–629.
doi: 10.1139/Y10-035
Kopp, U. C., Cicha, M. Z., Nakamura, K., Nüsing, R. M., Smith, L. A., and
Hökfelt, T. (2004). Activation of EP4 receptors contributes to prostaglandin
E2-mediated stimulation of renal sensory nerves. Am. J. Physiol. Renal. Physiol.
287, F1269–F1282. doi: 10.1152/ajprenal.00230.2004
Kopp, U. C., Cicha, M. Z., and Smith, L. A. (2002a). Endogenous angiotensin
modulates PGE(2)-mediated release of substance P from renal mechanosensory
nerve fibers. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R19–30.
doi: 10.1152/ajpregu.2002.282.1.R19
Kopp, U. C., Cicha, M. Z., and Smith, L. A. (2002b). PGE(2) increases release
of substance P from renal sensory nerves by activating the cAMP-PKA
transduction cascade. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R1618–
R1627. doi: 10.1152/ajpregu.00701.2001
Kopp, U. C., Cicha, M. Z., and Smith, L. A. (2003). Angiotensin blocks
substance P release from renal sensory nerves by inhibiting PGE2-mediated
activation of cAMP. Am. J. Physiol. Renal Physiol. 285, F472–F483.
doi: 10.1152/ajprenal.00399.2002
Kopp, U. C., Cicha, M. Z., Smith, L. A., Mulder, J., and Hökfelt, T. (2007). Renal
sympathetic nerve activity modulates afferent renal nerve activity by PGE2-
dependent activation of alpha1- and alpha2-adrenoceptors on renal sensory
nerve fibers. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, R1561–R1572.
doi: 10.1152/ajpregu.00485.2007
Kopp, U. C., Cicha, M. Z., Smith, L. A., Ruohonen, S., Scheinin, M., Fritz, N., and
Hökfelt, T. (2011). Dietary sodium modulates the interaction between efferent
and afferent renal nerve activity by altering activation of α2-adrenoceptors
on renal sensory nerves. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300,
R298–310. doi: 10.1152/ajpregu.00469.2010
Kopp, U. C., Farley, D. M., Cicha, M. Z., and Smith, L. A. (2000). Activation of
renal mechanosensitive neurons involves bradykinin, protein kinase C, PGE,
and substance P. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278, R937–R946.
doi: 10.1152/ajpregu.2000.278.4.R937
Kopp, U. C., Grisk, O., Cicha, M. Z., Smith, L. A., Steinbach, A., Schlüter,
T., et al. (2009). Dietary sodium modulates the interaction between efferent
renal sympathetic nerve activity and afferent renal nerve activity: role of
endothelin. Am. J. Physiol. Regul. Integr. Comp. Physiol. 297, R337–R351.
doi: 10.1152/ajpregu.91029.2008
Kopp, U. C., Matsushita, K., Sigmund, R. D., Smith, L. A., Watanabe, S., and
Stokes, J. B. (1998b). Amiloride-sensitive Na+ channels in pelvic uroepithelium
involved in renal sensory receptor activation. Am. J. Physiol. 275 (6 Pt 2),
R1780–R1792. doi: 10.1152/ajpregu.1998.275.6.R1780
Kopp, U. C., and Smith, L. A. (1993). Role of prostaglandins in renal sensory
receptor activation by substance P and bradykinin. Am. J. Physiol. 265(3 Pt 2),
R544–R551. doi: 10.1152/ajpregu.1993.265.3.R544
Kopp, U. C., and Smith, L. A. (1996). Bradykinin and protein kinase C activation
fail to stimulate renal sensory neurons in hypertensive rats. Hypertension
27(3 Pt 2), 607–612. doi: 10.1161/01.HYP.27.3.607
Kopp, U. C., Smith, L. A., and DiBona, G. F. (1985). Renorenal reflexes: neural
components of ipsilateral and contralateral renal responses. Am. J. Physiol.
249(4 Pt 2), F507–F517. doi: 10.1152/ajprenal.1985.249.4.F507
Krause, B. J., Casanello, P., Dias, A. C., Arias, P., Velarde, V., Arenas, G. A., et al.
(2018). Chronic intermittent hypoxia-induced vascular dysfunction in rats is
reverted by N-acetylcysteine supplementation and arginase inhibition. Front.
Physiol. 9:901. doi: 10.3389/fphys.2018.00901
Kumagai, H., Suzuki, H., Ryuzaki, M., Matsukawa, S., and Saruta, T. (1990).
Baroreflex control of renal sympathetic nerve activity is potentiated at early
phase of two-kidney, one-clip Goldblatt hypertension in conscious rabbits.Circ.
Res. 67, 1309–1322. doi: 10.1161/01.RES.67.6.1309
Kumar, G. K., Peng, Y. J., Nanduri, J., and Prabhakar, N. R. (2015).
Carotid body chemoreflex mediates intermittent hypoxia-induced oxidative
stress in the adrenal medulla. Adv. Exp. Med. Biol. 860, 195–199.
doi: 10.1007/978-3-319-18440-1_21
Kumar, P., and Prabhakar, N. R. (2012). Peripheral chemoreceptors:
function and plasticity of the carotid body. Compr. Physiol. 2, 141–219.
doi: 10.1002/cphy.c100069
Lai, C. J., Yang, C. C., Hsu, Y. Y., Lin, Y. N., and Kuo, T. B. (2006). Enhanced
sympathetic outflow and decreased baroreflex sensitivity are associated with
intermittent hypoxia-induced systemic hypertension in conscious rats. J. Appl.
Physiol. 100, 1974–1982. doi: 10.1152/japplphysiol.01051.2005
Lanfranchi, P., and Somers, V. K. (2001). Obstructive sleep apnea and vascular
disease. Respir. Res. 2, 315–319. doi: 10.1186/rr79
Liem, D. A., Verdouw, P. D., Ploeg, H., Kazim, S., andDuncker, D. J. (2002). Sites of
action of adenosine in interorgan preconditioning of the heart. Am. J. Physiol.
Heart Circ. Physiol. 283, H29–37. doi: 10.1152/ajpheart.01031.2001
Lin, C. S., Lee, S. H., Huang, H. S., Chen, Y. S., and Ma, M. C. (2015). H2O2
generated by NADPH oxidase 4 contributes to transient receptor potential
vanilloid 1 channel-mediated mechanosensation in the rat kidney. Am. J.
Physiol. Renal. Physiol. 309, F369–F376. doi: 10.1152/ajprenal.00462.2014
Lin, M., Liu, R., Gozal, D., Wead, W. B., Chapleau, M. W., Wurster, R.,
et al. (2007). Chronic intermittent hypoxia impairs baroreflex control of
heart rate but enhances heart rate responses to vagal efferent stimulation
in anesthetized mice. Am. J. Physiol. Heart Circ. Physiol. 293, H997–1006.
doi: 10.1152/ajpheart.01124.2006
Linley, J. E., Ooi, L., Pettinger, L., Kirton, H., Boyle, J. P., Peers, C., et al. (2012).
Reactive oxygen species are second messengers of neurokinin signaling in
peripheral sensory neurons. Proc. Natl. Acad. Sci. U.S.A. 109, E1578–E1586.
doi: 10.1073/pnas.1201544109
Linz, D., Mahfoud, F., Schotten, U., Ukena, C., Neuberger, H. R., Wirth, K.,et al.
(2012). Renal sympathetic denervation suppresses postapneic blood pressure
rises and atrial fibrillation in amodel for sleep apnea.Hypertension 60, 172–178.
doi: 10.1161/HYPERTENSIONAHA.112.191965
Loredo, J. S., Clausen, J. L., Nelesen, R. A., Ancoli-Israel, S., Ziegler, M.
G., and Dimsdale, J. E. (2001). Obstructive sleep apnea and hypertension:
are peripheral chemoreceptors involved? Med. Hypotheses 56, 17–19.
doi: 10.1054/mehy.2000.1086
Frontiers in Physiology | www.frontiersin.org 22 April 2019 | Volume 10 | Article 465
AlMarabeh et al. Renal Afferent Nerves and CIH-Induced Hypertension
Lu, W., Kang, J., Hu, K., Tang, S., Zhou, X., Xu, L., et al. (2017a). The
role of the Nox4-derived ROS-mediated RhoA/Rho kinase pathway in rat
hypertension induced by chronic intermittent hypoxia. Sleep Breath. 21,
667–677. doi: 10.1007/s11325-016-1449-2
Lu, W., Kang, J., Hu, K., Tang, S., Zhou, X., Yu, S., et al. (2017b). Angiotensin-
(1-7) relieved renal injury induced by chronic intermittent hypoxia in rats by
reducing inflammation, oxidative stress and fibrosis. Braz. J. Med. Biol. Res.
50:e5594. doi: 10.1590/1414-431x20165594
Lucking, E. F., O’Connor, K. M., Strain, C. R., Fouhy, F., Bastiaanssen, T.
F. S., Burns, D. P., et al. (2018). Chronic intermittent hypoxia disrupts
cardiorespiratory homeostasis and gut microbiota composition in adult male
guinea-pigs. EBioMedicine. 38, 191–205. doi: 10.1016/j.ebiom.2018.11.010
Lucking, E. F., O’Halloran, K. D., and Jones, J. F. (2014). Increased
cardiac output contributes to the development of chronic intermittent
hypoxia-induced hypertension. Exp. Physiol. 99, 1312–1324.
doi: 10.1113/expphysiol.2014.080556
Lurie, A. (2011). Endothelial dysfunction in adults with obstructive sleep apnea.
Adv. Cardiol. 46, 139–170. doi: 10.1159/000325108
Ma, M. C., Huang, H. S., Chen, Y. S., and Lee, S. H. (2008).
Mechanosensitive N-methyl-D-aspartate receptors contribute to
sensory activation in the rat renal pelvis. Hypertension 52, 938–944.
doi: 10.1161/HYPERTENSIONAHA.108.114116
Ma, M. C., Huang, H. S., Wu, M. S., Chien, C. T., and Chen, C. F. (2002). Impaired
renal sensory responses after renal ischemia in the rat. J. Am. Soc. Nephrol. 13,
1872–1883. doi: 10.1097/01.ASN.0000022009.44473.56
Machado, B. H., Zoccal, D. B., and Moraes, D. J. A. (2017). Neurogenic
hypertension and the secrets of respiration. Am. J. Physiol. Regul. Integr. Comp.
Physiol. 312, R864–R872. doi: 10.1152/ajpregu.00505.2016
Maggi, C. A., Santicioli, P., Del Bianco, E., and Giuliani, S. (1992). Local motor
responses to bradykinin and bacterial chemotactic peptide formyl-methionyl-
leucyl-phenylalanine (FMLP) in the guinea-pig isolated renal pelvis and ureter.
J. Urol. 148, 1944–1950. doi: 10.1016/S0022-5347(17)37090-8
Marcus, N. J., Li, Y. L., Bird, C. E., Schultz, H. D., andMorgan, B. J. (2010). Chronic
intermittent hypoxia augments chemoreflex control of sympathetic activity:
role of the angiotensin II type 1 receptor. Respir. Physiol. Neurobiol. 171, 36–45.
doi: 10.1016/j.resp.2010.02.003
Marcus, N. J., Philippi, N. R., Bird, C. E., Li, Y. L., Schultz, H. D., and
Morgan, B. J. (2012). Effect of AT1 receptor blockade on intermittent hypoxia-
induced endothelial dysfunction. Respir. Physiol. Neurobiol. 183, 67–74.
doi: 10.1016/j.resp,.2012.05.025
Marfurt, C. F., and Echtenkamp, S. F. (1991). Sensory innervation of the rat kidney
and ureter as revealed by the anterograde transport of wheat germ agglutinin-
horseradish peroxidase (WGA-HRP) from dorsal root ganglia. J. Comp. Neurol.
311, 389–404. doi: 10.1002/cne.903110309
McBryde, F. D., Liu, B. H., Roloff, E. V., Kasparov, S., and Paton, J. F. R. (2018).
Hypothalamic paraventricular nucleus neuronal nitric oxide synthase activity
is a major determinant of renal sympathetic discharge in conscious Wistar rats.
Exp. Physiol. 103, 419–428. doi: 10.1113/EP086744
Molkov, Y. I., Zoccal, D. B., Moraes, D. J., Paton, J. F., Machado, B. H.,
and Rybak, I. A. (2011). Intermittent hypoxia-induced sensitization of
central chemoreceptors contributes to sympathetic nerve activity during late
expiration in rats. J. Neurophysiol. 105, 3080–3091. doi: 10.1152/jn.00070.
2011
Moraes, D. J., Bonagamba, L. G., da Silva, M. P., Mecawi, A. S., Antunes-
Rodrigues, J., and Machado, B. H. (2016). Respiratory network
enhances the sympathoinhibitory component of baroreflex of rats
submitted to chronic intermittent hypoxia. Hypertension 68, 1021–1030.
doi: 10.1161/HYPERTENSIONAHA.116.07731
Moraes, D. J., Zoccal, D. B., and Machado, B. H. (2012). Medullary
respiratory network drives sympathetic overactivity and hypertension in
rats submitted to chronic intermittent hypoxia. Hypertension 60, 1374–1380.
doi: 10.1161/HYPERTENSIONAHA.111.189332
Moraes, D. J. A., da Silva, M. P., Spiller, P. F., Machado, B. H., and
Paton, J. F. R. (2018). Purinergic plasticity within petrosal neurons in
hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 315, R963–R971.
doi: 10.1152/ajpregu.00142.2018
Mulder, J., Hökfelt, T., Knuepfer, M.M., and Kopp, U. C. (2013). Renal sensory and
sympathetic nerves reinnervate the kidney in a similar time-dependent fashion
after renal denervation in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 304,
R675–R682. doi: 10.1152/ajpregu.00599.2012
Nagata, K., Osada, N., Shimazaki, M., Kida, K., Yoneyama, K., Tsuchiya, A., et al.
(2008). Diurnal blood pressure variation in patients with sleep apnea syndrome.
Hypertens. Res. 31, 185–191. doi: 10.1291/hypres.31.185
Naghshin, J., McGaffin, K. R., Witham, W. G., Mathier, M. A., Romano, L.
C., Smith, S. H., et al. (2009). Chronic intermittent hypoxia increases left
ventricular contractility in C57BL/6J mice. J. Appl. Physiol. 107, 787–93.
doi: 10.1152/japplphysiol.91256.2008
Narkiewicz, K., van de Borne, P. J., Montano, N., Dyken, M. E., Phillips, B.
G., and Somers, V. K. (1998). Contribution of tonic chemoreflex activation
to sympathetic activity and blood pressure in patients with obstructive sleep
apnea. Circulation 97, 943–945. doi: 10.1161/01.CIR.97.10.943
Nicholl, D. D., Hanly, P. J., Poulin, M. J., Handley, G. B., Hemmelgarn,
B. R., Sola, D. Y. and Ahmed, S. B. (2014). Evaluation of continuous
positive airway pressure therapy on renin-angiotensin system activity in
obstructive sleep apnea. Am. J. Respir Crit. Care Med. 190, 572–580.
doi: 10.1164/rccm.201403-0526OC
Oga, Y., Saku, K., Nishikawa, T., Kishi, T., Tobushi, T., Hosokawa, K., et al. (2018).
The impact of volume loading–induced low pressure baroreflex activation
on arterial baroreflex-controlled sympathetic arterial pressure regulation in
normal rats. Physiol. Rep. 6:e13887. doi: 10.14814/phy2.13887
O’Neill, J., Jasionek, G., Drummond, S. E., Brett, O., Lucking, E. F., Abdulla, M.
A., et al. (2019). Renal cortical oxygen tension is decreased following exposure
to long-term but not short-term intermittent hypoxia in the rat. Am. J. Physiol.
Renal Physiol. 316, F635–F645. doi: 10.1152/ajprenal.00254.2018
Oyarce, M. P., and Iturriaga, R. (2018). Contribution of oxidative stress and
inflammation to the neurogenic hypertension induced by intermittent hypoxia.
Front. Physiol. 9:893. doi: 10.3389/fphys.2018.00893
Ozkok, A., Kanbay, A., Odabas, A. R., Covic, A., and Kanbay, M.
(2014). Obstructive sleep apnea syndrome and chronic kidney disease:
a new cardiorenal risk factor. Clin. Exp. Hypertens. 36, 211–216.
doi: 10.3109/10641963.2013.804546
Pajolla, G. P., Accorsi-Mendonça, D., Lunardi, C. N., Bendhack, L. M., Machado,
B. H., and Llewellyn-Smith, I. J. (2009). Immunoreactivity for neuronal
NOS and fluorescent indication of NO formation in the NTS of juvenile
rats submitted to chronic intermittent hypoxia. Auton. Neurosci. 148, 55–62.
doi: 10.1016/j.autneu.2009.03.003
Patinha, D., Pijacka, W., Paton, J. F. R., and Koeners, M. P. (2017). Cooperative
oxygen sensing by the kidney and carotid body in blood pressure control. Front.
Physiol. 8:752. doi: 10.3389/fphys.2017.00752
Pawar, A., Nanduri, J., Yuan, G., Khan, S. A., Wang, N., Kumar, G. K., et al.
(2009). Reactive oxygen species-dependent endothelin signaling is required
for augmented hypoxic sensory response of the neonatal carotid body by
intermittent hypoxia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296, R735–
R742. doi: 10.1152/ajpregu.90490.2008
Peng, Y., and Prabhakar, N. (2008). Role of carotid bodies in chronic intermittent
hypoxia-evoked augmented LTF of phrenic nerve activity. FASEB. J. 22:960.7.
Peng, Y. J., Nanduri, J., Yuan, G., Wang, N., Deneris, E., Pendyala, S.,
et al. (2009). NADPH oxidase is required for the sensory plasticity of the
carotid body by chronic intermittent hypoxia. J. Neurosci. 29, 4903–4910.
doi: 10.1523/JNEUROSCI.4768-08.2009
Peng, Y. J., Raghuraman, G., Khan, S. A., Kumar, G. K., and Prabhakar,
N. R. (2011). Angiotensin II evokes sensory long-term facilitation of
the carotid body via NADPH oxidase. J. Appl. Physiol. 111, 964–970.
doi: 10.1152/japplphysiol.00022.2011
Peng, Y. J., Yuan, G., Khan, S., Nanduri, J., Makarenko, V. V., Reddy, V. D.,
et al. (2014). Regulation of hypoxia-inducible factor-α isoforms and redox
state by carotid body neural activity in rats. J. Physiol. 592, 3841–3858.
doi: 10.1113/jphysiol.2014.273789
Petho, G., and Reeh, P. W. (2012). Sensory and signaling mechanisms
of bradykinin, eicosanoids, platelet-activating factor, and nitric oxide in
peripheral nociceptors. Physiol. Rev. 92, 1699–1775. doi: 10.1152/physrev.0004
8.2010
Phillips, S. A., Olson, E. B., Lombard, J. H., and Morgan, B. J. (2006).
Chronic intermittent hypoxia alters NE reactivity and mechanics of
skeletal muscle resistance arteries. J. Appl. Physiol. 100, 1117–1123.
doi: 10.1152/japplphysiol.00994.2005
Frontiers in Physiology | www.frontiersin.org 23 April 2019 | Volume 10 | Article 465
AlMarabeh et al. Renal Afferent Nerves and CIH-Induced Hypertension
Pijacka, W., Katayama, P. L., Salgado, H. C., Lincevicius, G. S., Campos, R. R.,
McBryde, F. D., et al. (2018). Variable role of carotid bodies in cardiovascular
responses to exercise, hypoxia and hypercapnia in spontaneously hypertensive
rats. J. Physiol. 596, 3201–3216. doi: 10.1113/JP275487
Poonit, N. D., Zhang, Y. C., Ye, C. Y., Cai, H. L., Yu, C. Y., Li,
T., et al. (2017). Chronic intermittent hypoxia exposure induces kidney
injury in growing rats. Sleep Breath 22, 453–461. doi: 10.1007/s11325-017-
1587-1
Prabhakar, N. R., and Kumar, G. K. (2010). Mechanisms of sympathetic
activation and blood pressure elevation by intermittent hypoxia. Respir. Physiol.
Neurobiol. 174, 156–161. doi: 10.1016/j.resp.2010.08.021
Prabhakar, N. R., Kumar, G. K., and Nanduri, J. (2010). Intermittent hypoxia
augments acute hypoxic sensing via HIF-mediated ROS. Respir. Physiol.
Neurobiol. 174, 230–234. doi: 10.1016/j.resp.2010.08.022
Pratt-Ubunama, M. N., Nishizaka, M. K., Boedefeld, R. L., Cofield, S. S., Harding,
S. M., and Calhoun, D. A. (2007). Plasma aldosterone is related to severity
of obstructive sleep apnea in subjects with resistant hypertension. Chest. 131,
453–459. doi: 10.1378/chest.06-1442
Recordati, G. M., Moss, N. G., Genovesi, S., and Rogenes, P. R. (1980). Renal
receptors in the rat sensitive to chemical alterations of their environment. Circ.
Res. 46, 395–405. doi: 10.1161/01.RES.46.3.395
Recordati, G. M., Moss, N. G., and Waselkov, L. (1978). Renal chemoreceptors in
the rat. Circ. Res. 43, 534–543. doi: 10.1161/01.RES.43.4.534
Ribon-Demars, A., Pialoux, V., Boreau, A., Marcouiller, F., Larivière, R., Bairam,
A., and Joseph, V. (2018). Protective roles of estradiol against vascular oxidative
stress in ovariectomized female rats exposed to normoxia or intermittent
hypoxia. Acta. Physiol. 225:e13159. doi: 10.1111/apha.13159
Roy, A., Farnham, M. M. J., Derakhshan, F., Pilowsky, P. M., and Wilson, R. J. A.
(2017). Acute intermittent hypoxia with concurrent hypercapnia evokes P2X
and TRPV1 receptor-dependent sensory long-term facilitation in naïve carotid
bodies. J. Physiol. 596, 3149–3169. doi: 10.1113/JP275001
Saxena, A., Little, J. T., Nedungadi, T. P., and Cunningham, J. T. (2015).
Angiotensin II type 1a receptors in subfornical organ contribute towards
chronic intermittent hypoxia-associated sustained increase in mean
arterial pressure. Am. J. Physiol. Heart Circ. Physiol. 308, H435–H446.
doi: 10.1152/ajpheart.00747.2014
Schneider, M. P., Boesen, E. I., and Pollock, D. M. (2007).
Contrasting actions of endothelin ET(A) and ET(B) receptors in
cardiovascular disease. Annu. Rev. Pharmacol. Toxicol. 47, 731–759.
doi: 10.1146/annurev.pharmtox.47.120505.105134
Shah, N. A., Yaggi, H. K., Concato, J., and Mohsenin, V. (2010). Obstructive sleep
apnea as a risk factor for coronary events or cardiovascular death. Sleep Breath
14, 131–136. doi: 10.1007/s11325-009-0298-7
Shantha, G. P. S., and Pancholy, S. B. (2015). Effect of renal sympathetic
denervation on apnea-hypopnea index in patients with obstructive sleep
apnea: a systematic review and meta-analysis. Sleep Breath 19, 29–34.
doi: 10.1007/s11325-014-0991-z
Shao, W., Seth, D. M., Prieto, M. C., Kobori, H., and Navar, L. G. (2013).
Activation of the renin-angiotensin system by a low-salt diet does not augment
intratubular angiotensinogen and angiotensin II in rats. Am. J. Physiol. Renal
Physiol. 304, F505–F514. doi: 10.1152/ajprenal.00587.2012
Sharpe, A. L., Calderon, A. S., Andrade, M. A., Cunningham, J. T., Mifflin, S. W.,
and Toney, G. M. (2013). Chronic intermittent hypoxia increases sympathetic
control of blood pressure: role of neuronal activity in the hypothalamic
paraventricular nucleus.Am. J. Physiol. Heart Circ. Physiol. 305, H1772–H1780.
doi: 10.1152/ajpheart.00592.2013
Shell, B., Faulk, K., and Cunningham, J. T. (2016). Neural control of blood
pressure in chronic intermittent hypoxia. Curr. Hypertens. Rep. 18:19.
doi: 10.1007/s11906-016-0627-8
Shi, P., Diez-Freire, C., Jun, J. Y., Qi, Y., Katovich, M. J., Li, Q., Sriramula, S., et al.
(2010). Brain microglial cytokines in neurogenic hypertension. Hypertension
56, 297–303. doi: 10.1161/HYPERTENSIONAHA.110.150409
Silva, A. Q., and Schreihofer, A. M. (2011). Altered sympathetic reflexes and
vascular reactivity in rats after exposure to chronic intermittent hypoxia. J.
Physiol. 589 (Pt 6), 1463–1476. doi: 10.1113/jphysiol.2010.200691
Simone, S., Rascio, F., Castellano, G., Divella, C., Chieti, A., Ditonno, P.,
et al. (2014). Complement-dependent NADPH oxidase enzyme activation
in renal ischemia/reperfusion injury. Free. Radic. Biol. Med. 74, 263–273.
doi: 10.1016/j.freeradbiomed.2014.07.003
Smits, J. F., and Brody,M. J. (1984). Activation of afferent renal nerves by intrarenal
bradykinin in conscious rats. Am. J. Physiol. 247 (6 Pt 2), R1003–R1008.
doi: 10.1152/ajpregu.1984.247.6.R1003
Snyder, B., Shell, B., Cunningham, J. T., and Cunningham, R. L. (2017). Chronic
intermittent hypoxia induces oxidative stress and inflammation in brain
regions associated with early-stage neurodegeneration. Physiol. Rep. 5:e13258.
doi: 10.14814/phy2.13258
Sogawa, Y., Nagasu, H., Itano, S., Kidokoro, K., Taniguchi, S., Takahashi, M., et al.
(2018). The eNOS-NO pathway attenuates kidney dysfunction via suppression
of inflammasome activation in aldosterone-induced renal injury model mice.
PLoS ONE 13:e0203823. doi: 10.1371/journal.pone.0203823
Soukhova-O’Hare, G. K., Roberts, A. M., and Gozal, D. (2006). Impaired
control of renal sympathetic nerve activity following neonatal intermittent
hypoxia in rats. Neurosci. Lett. 399, 181–185. doi: 10.1016/j.neulet.2006.0
1.054
Souza, G. M., Bonagamba, L. G., Amorim, M. R., Moraes, D. J., and Machado, B.
H. (2016). Inspiratory modulation of sympathetic activity is increased in female
rats exposed to chronic intermittent hypoxia. Exp. Physiol. 101, 1345–1358.
doi: 10.1113/EP085850
Sriramula, S., Haque, M., Majid, D. S., and Francis, J. (2008). Involvement
of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt
appetite, hypertension, and cardiac hypertrophy. Hypertension 51, 1345–1351.
doi: 10.1161/HYPERTENSIONAHA.107.102152
Steinhoff, M. S., von Mentzer, B., Geppetti, P., Pothoulakis, C., and Bunnett, N. W.
(2014). Tachykinins and their receptors: contributions to physiological
control and the mechanisms of disease. Physiol. Rev. 94, 265–301.
doi: 10.1152/physrev.00031.2013
Stella, A., and Zanchetti, A. (1991). Functional role of renal afferents. Physiol. Rev.
71, 659–682. doi: 10.1152/physrev.1991.71.3.659
Sun, W., Yin, X., Wang, Y., Tan, Y., Cai, L., Wang, B., et al. (2012).
Intermittent hypoxia-induced renal antioxidants and oxidative damage
in male mice: hormetic dose response. Dose Response 11, 385–400.
doi: 10.2203/dose-response.12-027
Tahawi, Z., Orolinova, N., Joshua, I. G., Bader, M., and Fletcher, E. C. (2001).
Altered vascular reactivity in arterioles of chronic intermittent hypoxic rats. J.
Appl. Physiol. 90, 2007–13; discussion 2000. doi: 10.1152/jappl.2001.90.5.2007
Tamisier, R., Pépin, J. L., Rémy, J., Baguet, J. P., Taylor, J. A., Weiss, J. W., and Lévy,
P. (2011). 14 nights of intermittent hypoxia elevate daytime blood pressure
and sympathetic activity in healthy humans. Eur. Respir. J. 37, 119–128.
doi: 10.1183/09031936.00204209
Troncoso Brindeiro, C. M., da Silva, A. Q., Allahdadi, K. J., Youngblood, V.,
and Kanagy, N. L. (2007). Reactive oxygen species contribute to sleep apnea-
induced hypertension in rats. Am. J. Physiol. Heart Circ. Physiol. 293, H2971–
H2976. doi: 10.1152/ajpheart.00219.2007
Wainford, R., and Frame, A. (2017). The role of themechanosensitive renal sensory
afferent nerve sympathoinhibitory reno-renal reflex in sympathetic outflow,
natriuresis, and blood pressure regulation. FASEB. J. 31:718.
Wang, Y., Babánková, D., Huang, J., Swain, G. M., and Wang, D. H. (2008).
Deletion of transient receptor potential vanilloid type 1 receptors exaggerates
renal damage in deoxycorticosterone acetate-salt hypertension. Hypertension
52, 264–270. doi: 10.1161/HYPERTENSIONAHA.108.110197
Warchol-Celinska, E., Prejbisz, A., Kadziela, J., Florczak, E., Januszewicz, M.,
Michalowska, I., et al. (2018). Renal denervation in resistant hypertension
and obstructive sleep apnea: randomized proof-of-concept phase ii trial.
Hypertension 72, 381–390. doi: 10.1161/HYPERTENSIONAHA.118.11180
Wei, Q., Bian, Y., Yu, F., Zhang, Q., Zhang, G., Li, Y., et al. and Tong,
J. (2016). Chronic intermittent hypoxia induces cardiac inflammation and
dysfunction in a rat obstructive sleep apnea model. J. Biomed. Res. 30, 490–495.
doi: 10.7555/JBR.30.20160110
Weiss, M. L., and Chowdhury, S. I. (1998). The renal afferent pathways
in the rat: a pseudorabies virus study. Brain Res. 812, 227–241.
doi: 10.1016/S0006-8993(98)00950-0
Welch, W. J., Blau, J., Xie, H., Chabrashvili, T., and Wilcox, C. S. (2005).
Angiotensin-induced defects in renal oxygenation: role of oxidative stress. Am.
J. Physiol. Heart Circ. Physiol. 288, H22–H28. doi: 10.1152/ajpheart.00626.2004
Frontiers in Physiology | www.frontiersin.org 24 April 2019 | Volume 10 | Article 465
AlMarabeh et al. Renal Afferent Nerves and CIH-Induced Hypertension
Witkowski, A., Prejbisz, A., Florczak, E., Kadziela, J., Sliwinski, P., Bielen,
P., et al. (2011). Effects of renal sympathetic denervation on blood
pressure, sleep apnea course, and glycemic control in patients with
resistant hypertension and sleep apnea. Hypertension 58, 559–565.
doi: 10.1161/HYPERTENSIONAHA.111.173799
Wu, H., Zhou, S., Kong, L., Chen, J., Feng,W., Cai, J., et al. (2015). Metallothionein
deletion exacerbates intermittent hypoxia-induced renal injury in mice.
Toxicol. Lett. 232, 340–348. doi: 10.1016/j.toxlet.2014.11.015
Wu, K., Su, X., Li, G., and Zhang, N. (2016). Antioxidant carbocysteine treatment
in obstructive sleep apnea syndrome: a randomized clinical trial. PLoS ONE
11:e0148519. doi: 10.1371/journal.pone.0148519
Wu, X., Chang, S. C., Jin, J., Gu, W., and Li, S. (2018). NLRP3 inflammasome
mediates chronic intermittent hypoxia-induced renal injury implication of the
microRNA-155/FOXO3a signaling pathway. J. Cell. Physiol. 233, 9404–9415.
doi: 10.1002/jcp.26784
Wu, X., Gu, W., Lu, H., Liu, C., Yu, B., Xu, H., et al. (2016). Soluble
receptor for advanced glycation end product ameliorates chronic intermittent
hypoxia induced renal injury, inflammation, and apoptosis via P38/JNK
signaling pathways. Oxid. Med. Cell. Longev. 2016:1015390. doi: 10.1155/2016/
1015390
Wyss, J. M., Aboukarsh, N., and Oparil, S. (1986). Sensory denervation of the
kidney attenuates renovascular hypertension in the rat. Am. J. Physiol. 250 (1 Pt
2), H82–H86. doi: 10.1152/ajpheart.1986.250.1.H82
Xiang, Y. H., Su, X. L., He, R. X., andHu, C. P. (2012). Effects of different patterns of
hypoxia on renin angiotension system in serum and tissues of rats. Zhonghua Jie
He He Hu Xi Za Zhi. 35, 33–36. doi: 10.3760/cma.j.issn.1001-0939.2012.01.012
Xiang, Y. H., Su, X. L., Hu, C. P., Luo, Y. Q., and He, R. X. (2010). A study of
the related pathways of oxidative stress in chronic intermittent hypoxia rats
and the effect of N-acetylcysteine. Zhonghua Jie He He Hu Xi Za Zhi. 33,
912–916.
Xie, C., Sachs, J. R., and Wang, D. H. (2008). Interdependent regulation of afferent
renal nerve activity and renal function: role of transient receptor potential
vanilloid type 1, neurokinin 1, and calcitonin gene-related peptide receptors.
J. Pharmacol. Exp. Ther. 325, 751–757. doi: 10.1124/jpet.108.136374
Xu, B., Zheng, H., Liu, X., and Patel, K. P. (2015). Activation of afferent renal nerves
modulates RVLM-projecting PVN neurons. Am. J. Physiol. Heart Circ. Physiol.
308, H1103–H1111. doi: 10.1152/ajpheart.00862.2014
Xu, W., Chi, L., Row, B. W., Xu, R., Ke, Y., Xu, B., et al. (2004). Increased oxidative
stress is associated with chronic intermittent hypoxia-mediated brain cortical
neuronal cell apoptosis in a mouse model of sleep apnea. Neuroscience 126,
313–323. doi: 10.1016/j.neuroscience.2004.03.055
Yamamoto, K., Eubank, W., Franzke, M., and Mifflin, S. (2013). Resetting of
the sympathetic baroreflex is associated with the onset of hypertension
during chronic intermittent hypoxia. Auton. Neurosci. 173, 22–27.
doi: 10.1016/j.autneu.2012.10.015
Yu, J., Zhou, Z., McEvoy, R. D., Anderson, C. S., Rodgers, A., Perkovic, V., et al.
(2017). Association of positive airway pressure with cardiovascular events and
death in adults with sleep apnea: a systematic review and meta-analysis. JAMA
318, 156–166. doi: 10.1001/jama.2017.7967
Zhang, X. B., Cai, J. H., Yang, Y. Y., Zeng, Y. M., Zeng, H. Q., Wang, M., et al.
(2018). Telmisartan attenuates kidney apoptosis and autophagy-related protein
expression levels in an intermittent hypoxia mouse model. Sleep Breath. 23,
341–348. doi: 10.1007/s11325-018-1720-9
Zhang, Y., Su, X., Zou, F., Xu, T., Pan, P., and Hu, C. (2018). Toll-like receptor-
4 deficiency alleviates chronic intermittent hypoxia-induced renal injury,
inflammation, and fibrosis. Sleep Breath. doi: 10.1007/s11325-018-1704-9.
[Epub ahead of print].
Zhao, M. M., Tan, X. X., Ding, N., and Zhang, X. L. (2013). Comparison
of efficacy between continuous positive airway pressure and renal artery
sympathetic denervation by radiofrequency ablation in obstructive sleep
apnea syndrome patients with hypertension. Zhonghua Yi Xue Za Zhi. 93,
1234–1237. doi: 10.3760/cma.j.issn.0376-2491.2013.16.007
Zhu, Y., Xie, C., andWang, D. H. (2007). TRPV1-mediated diuresis and natriuresis
induced by hypertonic saline perfusion of the renal pelvis. Am. J. Nephrol. 27,
530–537. doi: 10.1159/000107665
Zoccal, D. B., Bonagamba, L. G., Antunes-Rodrigues, J., and Machado, B.
H. (2007a). Plasma corticosterone levels is elevated in rats submitted
to chronic intermittent hypoxia. Auton. Neurosci. 134, 115–117.
doi: 10.1016/j.autneu.2007.01.004
Zoccal, D. B., Bonagamba, L. G., Oliveira, F. R., Antunes-Rodrigues, J.,
and Machado, B. H. (2007b). Increased sympathetic activity in rats
submitted to chronic intermittent hypoxia. Exp. Physiol. 92, 79–85.
doi: 10.1113/expphysiol.2006.035501
Zoccal, D. B., Bonagamba, L. G., Paton, J. F., and Machado, B. H. (2009a).
Sympathetic-mediated hypertension of awake juvenile rats submitted to
chronic intermittent hypoxia is not linked to baroreflex dysfunction. Exp.
Physiol. 94, 972–983. doi: 10.1113/expphysiol.2009.048306
Zoccal, D. B., Huidobro-Toro, J. P., and Machado, B. H. (2011). Chronic
intermittent hypoxia augments sympatho-excitatory response to ATP but
not to L-glutamate in the RVLM of rats. Auton. Neurosci. 165, 156–162.
doi: 10.1016/j.autneu.2011.06.001
Zoccal, D. B., Paton, J. F., and Machado, B. H. (2009b). Do changes in
the coupling between respiratory and sympathetic activities contribute to
neurogenic hypertension? Clin. Exp. Pharmacol. Physiol. 36, 1188–1196.
doi: 10.1111/j.1440-1681.2009.05202.x
Zoccal, D. B., Simms, A. E., Bonagamba, L. G., Braga, V. A., Pickering, A. E., Paton,
J. F., and Machado, B. H. (2008). Increased sympathetic outflow in juvenile
rats submitted to chronic intermittent hypoxia correlates with enhanced
expiratory activity. J. Physiol. 586, 3253–3265. doi: 10.1113/jphysiol.2008.1
54187
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2019 AlMarabeh, Abdulla andO’Halloran. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Physiology | www.frontiersin.org 25 April 2019 | Volume 10 | Article 465
